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Summary
The mechanism of DCCD inhibition of ATP synthetase,
and the components of the mitochondrial membrane with
which DCCD interacts have been investigated. It has
been shown that DCCD inhibits ATP-dependant reactions in
■V+rat liver mitochondria and that C-DCCD is covalently
bound to a proteolipid with a molecular weight of 10,000
daltons. This proteolipid may be synthesised on
mitoribosomes. The role of the. membrane in the mechanism
2 +of inhibition of the Mg ATPase has been demonstrated by 
perturbation of the membrane with diethyl ether, such 
that inhibitor sensitivity, but not enzymic activity, 
is destroyed.
A series of oligomycin resistant mutants of 
Saccharomyces cerevisiae have been found to be cross- 
resistant to DCCD. An oligomycin (DCCD) sensitive ATPase 
has been prepared from the mitochondria of these mutants, 
and the mutant enzyme shown to possess a lowered sensitivity 
to DCCD. It is suggested that one of four subunits of 
the ATPase is the site of action of DCCD. It has been'l Zifound that the smallest subunit will bind C DCCD when 
the mitochondrial membrane is depleted of and OSCP.
This subunit has been extensively purified from mitochondria 
of both parental and oligomycin (DCCD) resistant strains 
of S. cerevisiae and the mutant peptide has been shown to 
differ in composition from that derived from the parental 
strain.
• ••
Abbreviations
ADP Adenosine 5' diphosphate
AMP-PNP Adenylyl imidodiphosphate
Asi Arsenate
ATP Adenosine 5' triphosphate
ATPase ATP phosphohydrolase (E.C. 3.6.1.A.)
DCCD Dicyclohexylcarbodiimide
DCU Dicyclohexylurea
DNP Dinitrophenol
EDTA Ethylene diamine tetraacetic acid
ETPr Sonic particles produced from beef heart 
mitochondria
F1 Soluble mitochondrial ATPase
NCCD N-(2,2,6,6,-tetramethyl-piperidyl-1-oxyl ) 
N' -(cyclohexyl)-carbodiimide
OS-ATPase Oligomycin sensitive ATPase
OSCP Oligomycin sensitivity conferring protein
Pi Phosphate
SDS Sodium dodecyl sulphate
SMP Submitochondrial particles
SMP (NaBr) Sodium bromide extracted SMP
SMP (NH^OH) Ammonia extracted SMP
SMP (Et20) Ether extracted particles
TCA Trichloracetic acid
Tris Tris-hydroxymethylaminomethane
y e tp Sonic particles prepared from yeast mitochondria
CFo-FI Olicronycin sensitive ATFase Troii bovine heart mitochondria.
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CHAPl'ER 1 INTRODUCTION
The mitochondrial Adenosine 5'-triphosphatase (ATPase; 
ATP phosphohydrolase, E.C. 3.6.1.4.) is a complex enzyme 
system, naturally occurring as a part of a membrane bound 
complex, which catalyses the hydrolysis of Adenosine 5' 
triphosphate (ATP) to Adenosine 5' diphosphate (ADP) and 
inorganic phosphate (Pi;. The first suggestion that the 
Mg^* ATPase activity of the mitochondrion might be 
associated with oxidative phosphorylation was made by Lardy 
in 1945 (1). The mechanism by which synthesis of ATP from 
ADP and Pi is coupled to the oxidation of intermediary 
metabolites by the electron transfer system is a matter of 
some controversy, but proponents of the chemical hypothesis 
(p), the chemiosmotic hypothesis (3), and the conformational 
hypothesis (4, 5 ; all identify the terminal phosphoryl 
transferase with Mgci+ ATPase.
The chemical hypothesis was formulated by analogy to 
glyceraldehyde-3-phosphate oxidation. The demonstration 
that energy transfer can take place between the individual 
coupling sites indicates that coupling may proceed by way 
of non-phosphorylated intermediates. These are postulated
1.1. The role of Mg^ + ATPase in oxidative phosphorylation
to be the electron carriers in the respiratory chain. The
reaction pathways leading to the formation of ATP are
suggested to be
a h2 + B + T ----- - A ~ I + bh2 (1)
A ~ I + X -C-----  A + X ~ I (2)
I— X + Pi I + X— P (3)
la
Footnote: Arsenate stimulated respiration is inhibited by phosphate 
and this inhibition is relieved by ADP.In the presence of aurovrtin the 
arsenate stimulated respiration is still inhibited by phosphate but 
the inhibition is no longer relieved by ADP.This is consistent with 
equations (/+)and (5)» and establishes the site of aurovertin inhibition 
as lying between X-P and ATP.At low concentrations of aurovertin, the 
inhibitor will inhibit arsenate stimulated respiration, suggesting that 
when aurovettin is absent,X-As is hydrolysed slowly and that most of 
the arsenate stimulated respiration is accounted for by participation 
of endogenous ADP (213).
Electron Transport
X-P X - A s ----------- X*  Asj
ADP *  As-
2X— P + ADP X + ATP (qj1 R 18Analysis of the 0 products following the HpO into Pi
and ATP (6, 7, 8) shows that 0 enters at the point of 
phosphate uptake, and that the oxygen in the terminal pyro­
phosphate linkage of ATP must be provided by a terminal 
oxygen from ADP rather than Pi. These observations suggest 
a X ADP intermediate in the formation of ATP as outlined in 
equation 4. The intermediate I ~ X  is postulated to explain 
the finding that DNP and arsenate act at two different levels 
of the energy transfer system, as revealed by studies with 
oligomycin. Oligomycin inhibits oxidative phosphorylation 
(9), the ATP - Pi exchange reaction (10) and the ATPase 
(11). Arsenate, which induces the ATPase reaction (12), 
does not relieve the inhibitory effect of oligomycin on 
tightly coupled respiration (1 3 )» unlike uncoupling agents.
This phenomenon permits a differentiation of the site of 
action of uncouplers from that of arsenate. Furthermore, 
it shows that oligomycin probably acts prior to the entry 
of phosphate. Oligomycin probably acts by inhibiting 
equation 2, accounting for its inhibition of arsenate 
uncoupled, but not uncoupler stimulated respiration. Arsenate 
acts by an arsenolytic reaction as described in equations 5 
and 6.
I ~ X  + Asi I + X ~Asi (5)
X — Asi + H20 ---- X + Asi (6)
Uncouplers are thought to act at A ~I.
The chemiosmotic hypothesis was postulated by Mitchell
(3), to provide an explanation for the requirement of an
intact membrane for phosphorylation, since this requirement 
is not implicit in the chemical-coupling hypothesis. It
3also sought to explain the failure of all attempts to 
identify the intermediates X and I. In its simplest form, 
the chemiosmotic hypothesis consists of the generation of 
a proton gradient across the proton impermeable inner 
membrane by the electron transport chain. This proton 
gradient then drives the synthesis of ATP from ADP and Pi 
by means of an anisotropic ATPase.
The proposal depends on the possibility that the ATPase 
may lie in the membrane, isolated from the aqueous phase on 
both sides, but accessible to 0H~ ions on one side and to H 
on the other. If we consider the hydrolysis of ATP,
ATP + HgO ...- ADP + Pi (7)
This reaction may be written
ATP + H + + OH- ?=s ADP + Pi (8)
showing that, given such an anisotropic ATPase, hydrolysis 
of ATP would be accompanied by the effective translocation 
of protons from one side of the membrane to the other. 
Similarly, the reverse reaction, ATP synthesis, could be 
effected by a flow of protons across the membrane in the 
opposite direction.
In the conformational hypothesis (4, 5) the driving 
force for the synthesis of ATP is a conformational change 
in the coupling apparatus. The basic unit of mitochondrial 
energy conservation is suggested to be a 1 supermolecule1 
(14). The supermolecule consists of two components, one of 
which catalyses a polarising reaction, and one which 
catalyses a depolarising reaction. The depolarising element, 
the ATPase, is polarised by separation of electrons and 
protons in the electron transfer complexes. A conformational
4strain is set up in the ATPase such that conditions are 
energetically suitable for a chemical reaction between ADP 
and Pi. When bond formation takes place, the conformational 
strain in the supermolecule is removed. Other postulated 
depolarising components, the transhydrogenase, transprotonase 
and transphosphorylase act via a similar mechanism, catalysing 
the transfer of hydride ion, protons, and phosphoryl groups 
respectively (14).
Supportive evidence for the proposed identity of Mg^ + 
ATPase and the terminal phosphoryl transferase in ATP 
synthesis is often ambiguous. Classically, investigation of 
the mechanism of oxidative phosphorylation has been carried 
out by preparation of respiring submitochondrial particles 
depleted of one or more proteins and lacking phosphorylation. 
Restoration of phosphorylation coupled to respiration 
(.monitored by inhibitor sensitive ATP synthesis or energy 
linked reactions) may be acheived by addition of soluble 
proteins removed from submitochondrial particles (.coupling 
factors). Over ¿0 such coupling factors of varying purity 
have been described (.15, 16), several of which possess ATPase 
activity (.17 - '¿ '¿ ) . The best characterised of these 
coupling factors is F,( (17). Removal of F^ from mitochondrial 
particles results in loss of oxidative phosphorylation and 
membrane bound ATPase activity (23). Addition of F^ to 
depleted particles stimulates oxidative phosphorylation,
ATP/Pi exchange and reversed electron transfer (17* 24, 25). 
Antibody to F inhibits oxidative phosphorytal'ion and the 
membrane bound ATPase (26). However, this stimulation by 
F is due, at least in part, to some organising ability of
the protein on the mitochondrial membrane. F^, dissociated 
and inactivated by oxidation of sulphydryl groups, will 
still stimulate oxidative phosphorylation in depleted 
particles (.27). Further evidence for F^ as a structural 
entity is provided by the work of Schatz (28). F^ from 
yeast mitochondria stimulates oxidative phosphorylation in 
beef heart mitochondrial particles if some beef heart F is 
present. Antibody to beef heart F^ does not remove the 
ATPase activity of yeast F,(, but abolishes the coupling 
activity. Antibody to yeast F^ inhibits the ATPase but not 
the coupling activity (¿8).
Perhaps the strongest evidence for involvement of the 
ATPase in ATP synthesis is provided by inhibitor studies. 
Inhibitors of oxidative phosphorylation include oligomycin 
(10), rutamycin (29), aurovertin (18, 30), dicyclohexyl- 
carbodiimide (31, 32), trialkyl tin chlorides (29, 33), 
venturicidin (34) and azide. These inhibitors a3so inhibit 
the membrane bound ATPase and a detergent solubilised 
preparation of the ATPase (29 - 34). Dio-9 (35) is a potent 
inhibitor of ATPase in yeast, but has little effect on the 
beef heart enzyme. However, only azide, aurovertin and 
Dio-9 inhibit the ATPase activity of F^. Moreover, the 
inhibitor protein of Pullman and Monroy (36), Adenylyl 
imidodiphosphate (AMP-PNP), and quercitin (37) inhibit both 
soluble and membrane bound ATPase activity but ao not 
inhibit oxidative phosphorylation (36 - 38). The inhibitors 
of oxidative phosphorylation which do not inhibit F^ may be 
shown to act at a site in the coupling mechanism prior to 
the entry of phosphate. The insensitivity of F^ to these
6inhibitors is thus explained by the lack of the proteins 
binding the inhibitors and which are presumably involved in 
the production of the high energy intermediate whether 
chemical, proton gradient, or charge separation. These 
proteins are however present in the detergent solubilised 
preparation (39).
' I .H . Oligomycin insensitive ATPase
Preparations of ATPase from mitochondria may be 
classified into oligomycin sensitive and insensitive enzymes. 
Where data concerning the sensitivity to other inhibitors is 
available, the oligomycin sensitive ATPase preparations are 
inhibited by compounds inhibiting oxidative phosphorylation, 
and the oligomycin insensitive preparations are inhibited 
by aurovertin (and possibly azide and bio-9). Numerous 
coupling factors with ATPase activity have been isolated but 
the most purified and best characterised are F ('17),
Factor A ('l9), and the 03-ATPase of Tzagoloff (39, 40).
F^ has been purified to homogeneity from yeast (4'i, 42), 
rat liver (43, 44), and beef heart ('17, 43) mitochondria.
Most methods for purification of F,( involve sonication of 
mitochondrial membranes followed by ion exchange chromatog­
raphy and gel filtration of the 'i00,000g supernatants. 
Activities for the enzymes are of the order of 50^j.moles ATP 
hydrolysed/minute/mg protein. The preparations are water- 
soluble, lipid-free and cold labile. F has an estimated 
molecular weight of p40,UUU (43).
Factor A, although similar to F in most respects, differs 
in that it has only a latent ATPase activity which is
stimulated by heat, and which is cold stable (’i9). The 
differences between 1’ and Factor A may be due to the absence 
of a heating step in'the purification of Factor A 09).
Sanadi has proposed that the ATPase activity is induced by 
a conformational change in the protein such that the avail­
ability of the active site to water is increased (46).
This would seem to be borne out by the low ATPase activity 
of intact mitochondria and the high ATPase activity of 
damaged mitochondria (47;. Pullman and Schatz have 
attributed the low ATPase activity of Factor A to the presence 
of ATPase inhibitor protein (48;. Sanadi, however, claims 
that F^ and Factor A contain the same amount of inhibitor 
protein.
Electroohoresis of F. under denaturing conditions shows 
that most preparations contain five subunits (49;. F^ 
prepared by the method of Horstman and Racker (30; contains 
a sixth subunit which may be the ATPase inhibitor protein.
The two largest peptide subunits have molecular weights 
between 50,000 and 62,000 (41, 43, 44, 31 - 33;. They 
comprise some 90% of the total protein as estimated by 
binding of stain in polyacrylamide gel electrophoresis. The 
third subunit has a molecular weight between 25,000 and 36,000 
(4 1j 43, 44, 51 -53), and is somewhat less than 10% of the 
total protein. The two minor subunits have molecular 
weights below 20,000. The stoichiometry of the peptides has 
been proposed to be A^B^CDE for both beef heart (49) and rat 
liver (53) F^. Evidence supporting the proposed subunit 
structure is (A) Electron micrographs show a hexameric 
arrangement of similar subunits (A and B) (B) A^B^CDE is
A
consistent with the dye binding of these subunits in SDS 
gel electrophoresis. It should be borne in mind that 
estimation of protein by staining intensity is not applicable 
to all proteins (56). One of the subunits of the oligornycin 
sensitive ATPase does not bind dye (57). (C) The number of
cysteines and half cystines in F^ is 12 (52). The 
arrangement A^B^CDE is consistent with 12 cysteines from the 
known amino acid composition.
All five of the subunits of beef heart F^ have been 
isolated in pure form (52, 55), and similar amino acid 
analyses obtained from two laboratories (52, 55) for the 
four largest subunits. There is some disagreement about 
the size and amino acid composition of the smallest subunit. 
Knowles and Penefsky (52) Suggest that the fifth subunit is 
a dimer, although this would seem improbable under the 
denaturing conditions used in SDS-gel electrophoresis.
Knowles and Penefsky (52) have also suggested that the fifth 
subunit of F^ is identical with the ATPase inhibitor protein 
of Pullman and Monroy (56), on the basis that the proteins 
have the same mobility in SDS gel electrophoresis and the 
same isoelectric point. It has since been shown that 
subunit five has a low inhibitory activity and that co- 
electrophoresis of subunit five and the ATPase inhibitor 
gave two distinct bands on electrophoresis. Moreover, the 
amino acid composition of inhibitor protein is known (10), 
and does not resemble that of subunit five according to
Knowies and Penefsky (52), or Senior and Brooks (55)-
1.3. Oligomycin sensitive ATPase
A variety of preparations of olivomycin sensitive ATPase 
from beef heart mitochondria have been published (58 - 62), 
of which the most purified is that of Swanljung (62). The 
majority of OS-ATPase nreparations from beef heart have not 
been purified to any great extent, the main contaminants 
being cytochromes, flavins and lipids. Most of the inform­
ation on the structure and composition of the OS-ATPase has 
been provided by the highly purified ATPase of Tzagoloff 
and Meagher (40), from yeast mitochondria. As in the case 
of Swanljung (61, 62), the ATPase is solubilised from the 
membrane by lov; concentrations of the non-ionic detergent 
Triton X-100, and is further purified by density gradient 
centrifugation. The purified preparation has a specific 
activity of 20 to 30 yu moles ATP hydrolysed/minute/mg 
protein, and is lipid activated. Unlike both and the 
OS-ATPase of Swanljung, it is cold stable. The level of 
phospholipid depletion is dependant on the concentration of 
triton used in the initial extraction.
All of the OS-ATPase preparations either contain 
phospholipids, or require phospholipid for maximal activity 
(40, 58 62). The OS-ATPase of Tzagoloff (60) from beef 
heart contains about 30% phospholipid and is not activated 
by addition of further phospholipid. The corresponding 
preparation from yeast may also contain up to 30% phospho­
lipid depending on the extraction conditions, but no data 
on activation by phospholipid has been reported (40). 
Activation of other OS-ATPase preparations by phospholipid 
has been described (58 - 64).
The most detailed studies of lipid activation are 
those of Swa-nljung (63)» and Cunningham (64). Both 
investigators agree that all phospholipids are competent 
to stimulate ATPase activity Maximal stimulation
is provided by lysolecithin. Swanljung et_ al. (64) 
have shown that addition of phospholipid lowers the Km 
(ATP) of the lipid depleted OS-ATPase from beef heart. 
Cunningham, however, has shown that the Km (ATP) of 
CFq-F^ is exactly the same in unactivated and asolectin 
treated preparations (63).
Perhaps the most significant result of Cunningham 
is the finding that there is no stimulation of CFq-F^ 
by diglycerides, although addition of phospholipids, 
fatty acids, monoolein or SDS gave rise to an oligomycin 
sensitive ATPase. The stimulation of OS-ATPase by such 
a diverse group of lipids suggests that the oligomycin 
sensitivity of the ATPase is not conferred by the 
lipophilic activators. Moreover, the only common property 
of the activating lipids is their amphipathic nature, 
and it is possible that their ability to stimulate the 
ATPase is due to this property. Verkleij (65) has 
shown that diglycerides differ from phospholipids in 
their inability to form a bilayer structure. The amphi­
pathic nature of phospholipids enables them to form 
laminar leaflets with a hydrophobic interior and polar 
groups projecting into the aqueous phase. It is possible 
that lipophilic activators stimulate the ATPase by 
providing a bilayer structure which s imulates the 
mitochondrial membrane.
The role of phospholipids in the mechanism of ATP 
synthesis and inhibitor sensitivity is still obscure, 
but it has been suggested that one of the functions of 
lipids is in linking the oligomycin insensitive ATPase 
to the other subunits of the OS-ATPase conferring 
oligomycin sensitivity. This is consistent with the work 
of Toson (66) and Lee (67) showing that F^ may be released 
from submitochondrial particles by incubation with excess 
phospholipid.
The OS-ATPase has a molecular weight of 468,000, 
based on sedimentation velocity, with an appropriate 
correction for 10% phospholipid content (40). The 
enzyme is separated into eight stained bands in SDS gel 
electrophoresis, and a ninth non-staining band which may 
be detected by incorporation of radiolabelled leucine 
during growth of the yeast cell (57). Some of these 
subunits may be accounted for as subunits held in common 
with F^, which may be prepared from the OS-ATPase by 
heating or salt extraction (68, 69). Tzagoloff has shown 
that subunits 1,2, 5» 4 and 8 are common to both F^ and 
OS-ATPase (40). The band with a molecular weight of 
12,000 daltons has been shown to be composed of two 
proteins on the basis of their differential sensitivity 
to inhibitors of cytoplasmic and mitochondrial protein 
synthesis ( 75). A summary of the molecular weights of 
the beef heart and yeast oligomycin sensitive and insen­
sitive ATPases is given in Table 1.
Negatively stained preparations of the inner 
mitochondrial membrane display a characteristic array of
î2
TABLE 1.1. Peptide subunits of OS-ATPase and
Preparation
Molecular
Weight
Yeast Yeast Beef Heart Beef Hea:
i-ATPase^ V OS-ATPase1 2  3*’5
73,000
58,000 58,000 55,000 53,000
54,000 54,000 52,000 50,000
38,000 38,000 30,000 -
31,000 31,000 29,000 25,000
29,000 - 20,000 -
22,000 - 19,000 -
18,500 - 12,500 12,500
12,000 12,000 10,000 -
7,500 - 8,000 7,500
1 J. Biol. Chem. 246. 7328
2 Biochem. Biophys. Res. Commun. ¿3, 1331
3 Biochemistry 2»/'596
4- FEBS Lett. 1Z, 327
5 Archiv. Biochem. Biophys. 140. 257
iOOÂ diameter spheres hound to the inner surface (59). 
These 'knobs' may be removed by treatments (sonication, 
salt extraction) which remove the oligomycin insensitive 
ATPase from the membrane, and may be replaced by reconst­
itution of depleted membranes with pure F^ (68, 69).
The inner membrane spheres are bound to the membrane by 
a 50 x 30Â 'stalk' which has been identified with a 
coupling factor conferring oligomycin sensitivity (70). 
This oligomycin sensitivity conferring protein (OSCP) 
has a molecular weight of 18,000 and accounts for band 7 
of the OS-ATPase SDS gel pattern (69). The protein is 
required for binding of to the membrane, and confers 
oligomycin sensitivity, although there is no evidence 
that it is the site of action of oligomycin, and it has 
been suggested (7 1) that the subunit should be renamed 
'basic coupling factor* in respect of its extremely 
basic nature (70).
The remaining four bands comprise the 'membrane 
factor', so called since it is the most insoluble part of 
the complex and may only be solubilised from the membrane 
by- detergents. All four proteins are extremely hydro- 
phobic, and belong to the class of proteolipids (7?). 
Although their function is not known, they are necessary 
for conferral of oligomycin sensitivity (69, 73), and may 
be involved in the binding of F^ and OSCP into the 
mitochondrial membrane during assembly of the OS-ATPase 
complex (69, 73 - 75). The smallest subunit has been 
purified from the OS-ATPase, and directly from submito- 
chondrial particles (57). Subunit 9 is soluble in
chloroform/methanol (2:1 v/v) and contains a high percent­
age of non-polar amino acids (57)- The other three 
peptides of the membrane factor are extractable only in 
acidic chloroform/methanol and have not been purified 
(76). The beef heart OS-ATPase has been shown to contain 
a peptide covalently binding DCCD (77) and a proteolipid 
binding DCCD has been isolated from beef heart mitochondria 
by chloroform/methanol extraction (78). The molecular 
weight of this DCCD-binding protein is 10,000.
The membrane factor peptides are usually assumed to 
be present in a 1:1 stoichiometry with . The molecular 
weight of the OS-ATPase is about 470,000 and that of F^ 
560,000. The molecular weights of the membrane factor 
peptides plus OSCP total 90,000 leaving a discrepancy of 
about 20,000 daltons. Beechey (71) has suggested that 
subunit 9 may be present in a 1:1 stoichiometry with the 
largest subunits of the oligomycin insensitive ATPase.
1.4 Biogenesis of ATPase components
Investigations in several laboratories (79, 80) 
have shown that mitochondria are semi-autonomous bodies 
containing informational DNA (79), mitoribosomes (80), 
and a mechanism for protein synthesis similar to, but 
distinct from, that carried out in the cytoplasm. One 
of the major differences between cytoplasmic and mito­
chondrial protein synthesis is the sensitivity to chlor­
amphenicol and the lack of inhibition by cycloheximide 
exhibited by the latter.(81). Amino acid incorporation 
into yeast mitochondria is also inhibited by other
antibiotics, such as erythromycin and lincomycin, which 
act in a similar manner to chloramphenicol (82). The 
majority of mitochondrial phospholipid and protein 
appears to be synthesised extramitochondrially, and 
subsequently transferred to the mitochondrion. Only 
about 10% of the total mitochondrial protein is synthesised 
by mitochondria.in rat liver (85).
There are two main approaches to the study of the 
nature of the proteins synthesised by mitochondria. The 
first involves the isolation of mitochondria, and incubation 
of these preparations with radioactive amino acids. The 
preparations may be washed and fractionated by conventional 
methods. Secondly, studies involving the incorporation 
of amino acids in vivo into mitochondria have been used 
to detect the distribution of radiolabelled peptides in 
both rat liver and yeast. The selective inhibition of 
mitochondrial protein synthesis by chloramphenicol and 
microsomal protein synthesis by cycloheximide has been 
used extensively in these experiments. The use of 
isolated mitochondria has been criticised on several 
grounds. Firstly, the incorporation of amino acids is 
slower in isolated mitochondria than in vivo (83).
Secondly, extreme care has to be taken to minimise any 
contribution arising from microsomal or bacterial contam­
ination (84). It seems, however, that the products of 
mitochondrial protein synthesis are similar in both vitro 
and vivr— S^Fri ) »
It has been shown that isolated rat liver mitochondria 
incorporate amino acids into the inner mitochondrial
4«
membrane only (86). Fractionation of th"5 inner mito­
chondrial membrane indicates that the proteins synthesised 
by the mitochondria are among the most insoluble of those 
in the membrane. No radioactive amino acids are 
incorporated into the readily soluble proteins of the 
mitochondrion (86 - 88). Electrophoresis in SDS of
submitochondrial particles prepared from rat liver mito-
xchondria incubated with H leucine and cycloheximide shows 
that the main product of mitochondrial protein synthesis 
has a molecular weight of about 40,000 daltons (89).
Three peptides with molecular weights of 48,000; 28,000;
20.000 and three peptides of lower molecular weight may 
also be detected.(89). Tzagoloff has shown that the main 
products of mitochondrial protein synthesis in yeast have 
molecular weights of 4-5,000, 29,000, 21,000, 12,000 and 
7,800 (75). The results of Thomas and Williamson are in 
general agreement with these findings, with the exception 
of an additional peptide with a molecular weight of
35.000 (90). It was also found that the largest and 
smallest mitochondrially synthesised peptides selectively 
incorporated %-2-glycerol (90). Further fractionation 
of the inner mitochondrial membrane has shown the presence 
of several of these peptides in the OS-ATPase (75)-
Most of the information on the biosynthesis of the 
ATPase complex has come from the elegant experiments of 
Tzagoloff (57). Glucose repressed yeast grown in derep­
ression medium containing chloramphenicol have a constant 
level of ATPase in the mitochondrial fraction but an 
ATPase activity, sensitive to antibody to F^, is to be
found in the post-ribosomal supernatant. This soluble
ATPase is not found if cycloheximide is present (91).
14If chloramphenicol and C leucine are included in the 
derepression medium, then the cytoplasmic protein synthesis 
products become labelled. Purification of the ATPase 
produced under these- conditions gives a preparation with 
five peptide subunits which co-electrophorese with a 
^H-leucine labelled preparation of F^ (92). Similar 
results are obtained if the soluble enzyme is prepared 
from petite mutants (57). It. would seem therefore that 
all of the peptides of are synthesised outside the 
mitochondrion. The biosynthesis of the oligomycin 
sensitivity conferring protein has been investigated by 
essentially the same means as F^  (69)» The problem is 
complicated by the lack of any known enzymic activity of 
OSCP, and the protein must be assayed by its ability to 
stimulate the binding of F^ to depleted membranes. The 
synthesis of OSCP has been found to be inhibited by 
cycloheximide, but not by chloramphenicol, indicating a 
cytoplasmic origin for this peptide (69). F^ and OSCP 
do not appear to be present as a complex in the post- 
ribosomal supernatant.
Investigation of the origin of the membrane factor 
of OS-ATPase suffers from the same problems as studies 
on OSCP. No known enzymic activity can be ascribed to 
the membrane factor, nor is there a satisfactory method 
of purification of this portion of the complex. The 
increase in the membrane factor during derepression is 
therefore monitored by the ability of NaBr-Alkali extracted
particles to bind F^ and confer oligomycin sensitivity.
The ability of these membranes to bind F^ increases during 
derepression, and is inhibited by both cycloheximide and 
chloramphenicol. If the cells are grown in chloramphenicol 
first and then in cyclobeximide, then there is no 
inhibition of membrane factor synthesis; this is not true 
if the order of the inhibitors is reversed. These 
findings indicate mitochondrial synthesis of the membrane 
factor in the presence of cycloheximide (70). If 
leucine is included in the derepression medium with 
cycloheximide, the mitochondrial protein is labelled. 
Extraction of such mitochondria with Triton to remove the 
OS-ATPase, and precipitation of the Triton extract with 
antisera to OS-ATPase, gives rise to a preparation 
displaying four radioactive subunits in SDS gel electro­
phoresis (75). Similar results are obtained if depleted 
particles, labelled in the presence of cycloheximide, are 
reconstituted with unlabelled F^ and OSCP (70). The 
major product is a low molecular weight peptide which is 
identified with subunit 9 of the ATPase on the basis of 
migration within polyacryamide gel (57, 75). The three 
other peptides migrate in the region of subunits 5, 6 
and 8 (57, 75).
The four membrane factor peptides have been shown to 
be proteolipids, and extraction with chloroform methanol 
of submitochondrial particles or OS-ATPase derived from 
cells grown in the presence of leucine and cycloheximide 
removes a single peptide of molecular weight 7,500 which 
co-electrophoreses with subunit 9 (57). The other
membrane factor subunits have not been purified but may 
be extracted with acidic chloroform-methanol (2:1 v/v)
(57»76). Thomas and Williamson have also reported 
extraction of two mitochondrially synthesised peptides 
from yeast mitochondria by chloroform-methanol (95).
3These two peptides, which incorporate H-glycerol have 
molecular weights of 11,000 and 48,000 and probably 
correspond to subunit 9 and a polymer or association 
product of subunit 9. Tzagoloff has shown that counts 
associated with a peptide of molecular weight 45,000 are 
to be found co-migrating with subunit 9 after treatment 
with base (57, 76).
Although there is no satisfactory preparation for 
OS-ATPase from rat liver mitochondria, Burke and Beattie 
(94) have shown that about 15% of the leucine 
incorporated into isolated rat liver mitochondria are 
extracted by chloroform-methanol. The incorporation is 
inhibited by chloramphenicol and carbomycin, both specific 
inhibitors of mitochondrial protein synthesis. Chloroform 
methanol extraction of labelled particles leads to a 
decrease in the label associated with a peptide of 
molecular weight 40,000, and total removal of two low 
molecular weight products (95)» About 20% of the total 
label may be extracted into acidic chloroform-methanol.
The results of Kuzela et al. (96) and Kadenbach (97) from 
in vivo incorporation into rat liver, are in general 
agreement with these findings. Kuzela finds that the 
major product is a peptide soluble in neutral chloroform 
methanol with a molecular weight of 9,000 (96). Burke
10a
SYNTHESIS OF STJT3XJNITS 0? YEAST O S-A TPase.
COMPONENT MOLECULAR WEIGHT. SITE OF SYNTHESIS.
FI 58,500 Cytoplasmic.
F1 54,000 Cytoplasmic.
F1 38,500 Cytoplasmic.
F1 31,000 Cytoplasmic.
F1 12,000 Cytoplasmic.
OSCP 18,500 Cytoplasmic.
Fo 29,000' Kitochond rial.
Fo 22,000 Mitochondrial.
Fo 12,000 Mitochondrial.
Fo 7,000 Mitochondrial.
II.B. The site of synthesis of mitochondrial components is not proven 
unambiguously by inhibition by eithe: chloramphenicol or cycloliexiraide, 
due to the interdependence of the cytoplasmic and mitochondrial 
protein syt.hesising systems.The following criteria have to be met 
before assigning mitochondrial synthesis.
a) Synthesis is inhibited by chloramphenicol and not by cycloheximide.
b) The product is absent in petite mutants.
c ^ Synthesis is possible in isolated mitochondria.
Conversely,the protein may be said to be nuclear coded if
a) Synthesis is inhibited by cycloheximide but not by chloramphenicol.
b) The protein is present in petite mutants.
c) Synthesis is not possible in isolated mitochondria.
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and Beattie have reported that chloroform-methanol 
extraction of lyophilised, labelled particles removes 
label associated with two broad bands in SDS gels in the 
molecular weight region 10 - 14,000. No significant 
counts are found in the higher molecular weight regions 
of the gel (95). It is possible that the 40,000 
molecular weight product is produced by association with 
other products in the same way as the 45,000 molecular 
weight product in yeast.
1.5 The use of mutants in bioenergetics
The use of mutants in the elucidation of metabolic 
pathways has become a standard tool of the research 
biochemist. The mutant approach in bioenergetics has 
been severely limited by the lack of suitable mutants and 
difficulties in fractionating the membrane bound enzymes 
involved.
Bacterial mutants deficient in energy conservation 
have been produced only recently, although the genetics of 
Escherichia coli are well characterised, and the problems 
arising from synthesis due to mitochondrial DNA and nuclear 
DNA are not found in procaryotes. Mitochondrial and 
bacterial oxidative phosphorylation probably operate by 
similar mechanisms (98). Suitable mutants of E. coli 
produced by Cox and Gibson (99, 100) have defects in the 
ATPase, or the coupling membrane proteins, and may prove 
valuable in the investigation of the coupling process. 
Mutants of Streptococcus faecal is resistant to DCCD have
been isolated and the involvement of a membrane bound
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coupling factor shown (101). Suitable preparations of 
bacterial membrane factors have not yet been described.
Mutants derived from eucaryotic organisms, especially 
yeast, have provided most of our information concerning 
the biosynthesis and nature of the coupling system. Yeast 
is a particularly suitable organism for a combined genetic 
and biochemical investigation on several counts. Yeast 
is one of the simplest of eucaryotes, and may be pheno- 
typically manipulated by defined changes in the growth 
conditions. Petite positive yeast strains may survive 
drastic alteration in their mitochondrial DNA, including 
total deletion. The biochemistry of yeasts is well 
known.
The production or isolation of suitable mutants 
should be followed by screening proceedures to determine 
the method of inheritance. The isolation and screening 
proceedures for mutants of £>. cerevisiae have been 
reviewed (102). Following preliminary screening, the 
mutants should be investigated at both mitochondrial and 
enzyme level, the ultimate aim being to equate a point 
mutation with an amino acid change in a specific peptide.
The petite mutation (103) represents a considerable 
deletion of mitochondrial DNA and is expressed as an 
inability to carry out mitochondrial protein synthesis.
Any property or peptide absent in petite mitochondria may 
therefore be assumed to be synthesised on mitoribosomes 
or be linked to products of such synthesis. Petites, 
although possessing an ATPase, do not show oligomycin 
sensitivity of this activity. In addition, it has been
shown that petites do not possess an ATP/Pi exchange.
These observations may indicate that the subunits of the 
OS-ATPase which are responsible for conferring oligomycin 
sensitivity are required for effective functioning of the 
ATP synthetase in energy conservation.
It has also been shown that the mitochondrial membrane 
in petites is rather impermeable to protons, although this 
may be abolished by uncouplers (104). Although the 
membrane is capable of charge separation, it is thought 
that the mechanism by which charge separation arises is 
inoperative. This may be linked to the absence of the 
membrane factor peptides of the ATPase, and to a disturbance 
of the respiratory chain (cytochromes a and b are absent in 
petites). Similarly it has been reported that the 
atractyloside sensitive adenine nucleotide translocase 
is not present in petites, although this is a matter of 
some dispute (105, 106).
Kovac has isolated a slow growing mutant with normal 
respiration and cytochromes (107). This op^ mutant has 
since been shown to be nuclear and has a defective adenine 
nucleotide translocase, but a normal ATPase (108).
Other nuclear mutants of S. cerevisiae have been shown to 
lack subunits of F^ (109).
An alternative approach to the isolation of mutants 
with altered components of the energy conservation system 
has been adopted by Griffiths (110 - 115). Mutants have 
been selected for growth on non-fermentable substrate in 
the presence of inhibitors of oxidative phosphorylation.
Any such mutants not due to cell or mitochondrial membrane
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impermeability or detoxification may be due to a 
modified ATPase complex. Mutants resistant to oligomycin 
(110, 111), triethyl tin (112, 113) and venturicidin (114, 
115) have been isolated. The mutants may be grouped into 
Class 2 mutants, which are specifically resistant to 
inhibitors of oxidative phosphorylation, and Class 1 
mutants, which are cross resistant to a wide range of 
inhibitors, uncouplers and inhibitors of protein synthesis. 
Class 1 mutants are considered to be general membrane 
mutants.
Class 2 oligomycin resistant mutants have been shown 
to be cytoplasmic (110) and map at two loci, 0L1 and 
OL11, on the mitochondrial genome (111). Decreased 
sensitivity to oligomycin has been shown in the mito­
chondrial ATPase, ATP/Pi exchange and ADP stimulated 
respiration of the mutants, and in purified preparations 
of the oligomycin sensitive ATPase (116). Class 2 
triethyl tin resistant mutants have also been shown to 
be cytoplasmic and map at the T locus (113). Decreased 
sensitivity to triethyl tin is found in the ATPase and 
ADP stimulated respiration of Class 2 mutants but is not 
as marked as in the oligomycin resistant mutants (113). 
Mitochondrial venturicidin resistant mutants (114) map 
at two loci, those exhibiting cross-resistance to oligomycin 
mapping at the OL 111 locus which is closely linked to OL 1
(114), and those exhibiting cross-resistance to triethyl 
tin mapping at the V 1 locus (114). It is likely from 
the combined biochemical and genetic data, that OL 1 and 
OL 111 are on the same cistron although some differences
?A
in the response of the ATFase to oligomycin are found 
(114). Venturicidin mutants mapping at V 1 are very 
similar to the triethyl tin mutants mapping at T 1, and 
it seems likely that T 1 and V 1 are identical, especially 
since the triethyl tin mutants have since been shown to 
he cross-resistant to venturicidin. All of the available 
evidence suggests that OL 1, OL 11 and V 1 are located on 
separate cistrons (114).
The resistance phenomenon may be explained by a 
binding of oligomycin at three attachment points, modific­
ations of which arise by mutation at loci OL 1, OL 11 and 
OL 111. Venturicidin binding is at two attachment points 
modified by OL 111 and V 1. The similarity in structure 
between oligomycin and venturicidin would suggest they 
have a common binding site (OL 111). It is also 
possible that OL 1, OL 11 and OL 111 represent modification 
of peptides not directly involved in the binding of 
oligomycin, but which induce an unfavourable conformation 
at the binding site. The binding of inhibitors to the 
OS-ATPase has been shown to be highly sensitive to 
conformational change (117)»
1.6 Reactions catalysed by the OS-ATPase complex
It is difficult to see why the OS-ATPase is such a 
large, assymetric complex. The only known activity of the 
complex is the hydrolysis/synthesis of ATP, coiipled to a 
transmembrane movement of protons (118). It has been 
suggested that there are two catalytic sites on the 
enzyme, one specialised for ATP synthesis and one
specialised for ATP utilising reaction. Support for 
this theory comes from the differential effects of 
aurovertin (18), AMP-PNP (119), qucrcitin (37) and the 
inhibitor protein of Pullman and Monroy (36) on oxidative 
phosphorylation and ATP requiring reactions.
It is well known that a tenfold greater concentration 
of aurovertin in required to inhibit the ATPase than 
oxidative phosphorylation. Mitchell has suggested on 
kinetic grounds (120) that aurovertin increases the 
affinity of the enzyme for ATP and decreases the affinity 
for ADP. Chang and Penefsky (121) have suggested that 
there are two aurovertin binding sites, one involved in 
the inhibition of oxidative phosphorylation and one 
involved in the inhibition of ATPase. Van de Stadt (122) 
has shown that aurovertin may be used as a probe of ATPase 
conformation, and proposes that a high affinity sitfe,, 
inhibiting oxidative phosphorylation, is induced by ATP 
and Pi, while an ADP stabilised low affinity site is 
responsible for the inhibition of ATPase.
The inhibitor protein of Pullman and Monroy (36), 
quercitin (37) and AMP-PNP do not inhibit oxidative 
phosphorylation, but inhibit ATPase and ATP dependant 
reactions. Penefsky has suggested that the site of ATP 
synthesis is insensitive to AMP-PNP, while a second site 
specialised for ATP utilising reactions is inhibited (123).
Two binding sites for ADP have been found in beef 
heart (124), a high affinity site (Kd 0.28 pM) and a 
low affinity site (Kd 47 p M) suggested to be the ATPase 
site because of the similarity of the dissociation constant
with the inhibition constant of AI)P for ATPase (124).
According to Mitchell (125, 126) the membrane factor 
peptides conferring oligomycin and DCCD sensitivity on F^ 
may also be responsible for the translocation of protons. 
This suggestion is supported by the experiments of Hinkle 
(127) showing that oligomycin and DCCD inhibit the 
permeability of F^ -depleted particles to protons. Also 
certain bacterial mutants or bacterial vesicle preparations 
lacking energy linked reactions may have some degree of 
restoration conferred by low concentrations of DCCD or 
oligomycin (128). Moreover petites (103), lacking the 
membrane factor peptides (57, 129), have a relatively low 
permeability to protons, which may be increased by 
uncouplers (104). According to Mitchell, the membrane 
factor peptides may provide a translocation pathway 
the membrane permitting access of protons and water to 
F^. This theory is attractive in that F^ has the same 
enzymic function in the membrane bound or isolated state 
(125).
It ispossible that some of the subunits of the 0S- 
ATPase catalyse other enzymic activities. If the membrane 
subunits are responsible for H + translocation, it may be 
that other transport proteins may be located in the 
complex. Kadenbach (131, 152) has found that chloroform- 
soluble proteins from rat liver mitochondria bind phosphate 
strongly, and that this binding is sensitive to thiol 
reagents such as N-ethylmaleimide which are inhibitors of 
phosphate transport (13^)- Oligomycin DCCD and
tributyl tin, which inhibit ATPase activity, have no effect
on the phosphate transporter (133). It is also interesting 
that a proteolipid from pig heart mitochondria has been 
shown to possess a high affinity for glutamate (13 0^ .
It has also been suggested that at least one of the 
subunits of OS-ATPase may be held in common with ADP 
translocase (135). Triethyl tin mutants of S. cerevisiae 
(112) have been shown to possess cross-resistance to 
bongkrekic acid, a good inhibitor of ADP translocation 
(136, 137).
The possibility of an intraction between the ADP carrier and the coupling 
sytera of oxidative phosphorylation has reviewed by Vpgnais et al (211) 
and recieves strong support from observations showing that the the 
phosphorylation of external ADP can be accomplished without the obli­
gatory flux of adenine nucleotides into and out of the mitochondrial 
matrix(212).Vignais suggests that ATP is released as free nucleotide 
from the F1-ATPase into a microaqueous space to which the ADP carrier 
has direct access(2ll).
Footnote;summation of the effects of oligonycin and DCCD has only been 
shown for stimulation of the ATP driven reduction of HAD*’by succinate.
For any given concentration of DCCD, the rate of reduction of NAD is 
increased by oligomycin up to a total concentration of 0.5nmole of 
(DCCD+oligomycin)/mg protein.These results are interpreted by the a 
authors as showing that the sites of DCCD and oligomycin inhibition 
are close enough to exclude the approach of a second inhibitory molecule 
, or that the two inhibitors share a common site.Aurovertin,in conjunction 
with oligonycin gives a rate less than that provided by oligomycin alone 
, suggesting that aumrertin acts at a separate site to oligomycin and 
to DOGD.
CHAPTER 2 INHIBITION OP ENERGY LINKED REACTIONS IN RAT
LIVER MITOCHONDRIA BY DCCD
2.1 Introduction
DCCD inhibits a range of energy linked reactions in 
mitochondria. In general, DCCD behaves in a similar 
manner, and at comparable levels, to the fungal antibiotic 
oligomycin (10). Both DCCD and oligomycin inhibit the 
uncoupler stimulated ATPase, ATP/Pi exchange, ATP dependant 
transhydrogenase, energy linked reduction of NAD by 
succinate, and ADP stimulated respiration in ETP^ and beef 
heart mitochondria (138, 139). The effects of oligomycin 
and DCCD are additive (139). Unlike oligomycin, the 
effects of DCCD cannot be reversed by repeated washing 
with phospholipid (139). The reactive nature of DCCD
(140) leads one to believe that the inhibitor forms a 
covalent bond with some molecule in the mitochondrial 
membrane which is concerned with energy conservation 
reactions. The value of such an inhibitor lies in the 
possibility of covalently labelling a specific site which 
can be shown to be involved in the synthesis of ATP.
Cattell et al. (78) have shown that beef heart submito-
"I ¿L . .chondrial particles, treated with C DCCD at levels giving 
sub-maximal inhibition of ATP dependant reactions, retain 
90% of the applied radiolabel. They have further shown 
that this Pound radioactivity is associated with a 
chloroform/methanol soluble proteolipid with a molecular 
weight of 10,000 daltons.
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Chloramphenicol sensitive incorporation in vitro of 
amino acids into the chloroform-methanol soluble proteins 
of rat liver mitochondria has been reported by Beattie 
(95)- In vivo incorporation of amino acids into the 
proteolipid fraction of rat liver mitochondria has been 
demonstrated by Kuzela (96) and Kadenbach (97). Amino 
acid incorporation into oroteolipids has also been shown 
to occur in the biogenesis of yeast mitochondria (57, 76,
93). The similarities between the products of mito­
chondrial protein synthesis and the DCCD binding protein 
in beef heart mitochondria may be due to identity of one 
of the mitochondrial products with the "Beechey protein", 
although DCCD binding and chloramphenicol sensitive 
incorporation have not been shown in the same system.
2.2. Methods and Materials
Sterile preparation of rat liver mitochondria
Rats were killed by stunning and partial exsanguination. 
The abdomen was washed with 90% ethanol, and the liver 
dissected out and washed in three changes of sterile 250tnM 
sucrose, and transferred to a sterile, tared, beaker. 
Approximately 15g of liver were homogenised in 40 ml of 
sterile 250mM sucrose 1mM EDTA, with 2 to 3 passes of a 
glass-teflon homogeniser. The homogenate was centrifuged 
twice at 800g for 20 minutes, the pellets being discarded.
The supernatant was centrifuged at 9,000g for 10 minutes, 
and the supernatant and loosely packed pellet of raicrosomes 
discarded. The brown hard packed pellet of mitochondria 
was resuspended in 250mM sucrose 1mM EDTA in a sterile
homogeniser, and centrifug;ed at 9,OOOg, the supernatant 
and pink layer of microsomes again being discarded. The 
mitochondrial pellet was washed again, and finally 
resuspended in a small volume of 250mM sucrose 1mM EDTA.
All steps were carried out at 0°C. All glassware and 
dissecting instruments were sterilised by heating at 
160°C overnight, or by flaming in ethanol.
Protein estimation
Mitochondrial protein was estimated by the biuret 
method of Gornall et al. (141), proteolipid was estimated 
by the Folin method as modified by Hess and Lewin (142).
Polyacrylamide Gel Electrophoresis
SDS-Polyacrylamide gel electrophoresis in 10% gels was 
essentially carried out by the method of Weber and Osbourne 
(143). Samples were dissolved at 1mg/ml in 0.1M 
phosphate buffer, 3% SDS, 5mM DTT, 5% mercaptoethanol, 
pH 10.
Gels were stained in 0.25% Coomassie brilliant blue 
in 45% methanol, 10% acetic acid, and destained in the 
same solvent. Gels containing radioactivity were sliced 
into 1mm sections and dissolved in 1ml of hydrogen 
peroxide at 50°C overnight.
Counting
•T A ¿1Counting of PH and C was carried out in a Packard 
Tricarb scintillation counter using a Triton X-100/toluene/ 
butyl PBD scintillation cocktail (144).
Assays
Polarography was carried out according to the method
Oof Nijs (1A-5). ATPase activity was measured by the method 
of Pullman (146) in a volume of 1ml at 50°C. ATP driven 
reduction of NAD by succinate and ATP driven energy linked 
nicotinamide nucleotide transhydrogenase were assayed 
by the methods of Low and Vallin (147) and Danielson and 
Ernster (148) as modified by Beecbey (149).
Incubation of mitochondria with DGCD
Membranes were incubated with DCCD in 250mM sucrose,
1410mM Tris-sulphate pH 7.4, 1mM ATP, 1mM succinate. C
DCCD treated membranes were washed with 250mM sucrose,
10mM Tris-sulphate pH 7.4 as described by Cattell ejfc al. 
(78). Extraction of the DCCD treated mitochondria with 
chloroform/methanol and purification of the proteolipid 
fraction was performed as described by Cattell at al. 
for beef heart mitochondria (78).
Amino Acid incorporation
In vitro incorporation of amino acids into rat liver 
mitochondria was carried out according to the procedure 
of Beattie (84). 1.25 pCi of a 5H (U) amino acid mixture
(Chlorella protein hydrolysate obtained from the Radio­
chemical Centre, Amersham) was added per mg of mitochondrial 
protein. Bacterial contamination was estimated by olating 
out aliquots of the mitochondrial suspension onto nutrient 
agar plates and incubating at 30°C for 5 days. In vivo 
incorporation of %  leucine (Radiochemical Centre,
Amersham) was carried out as described by Kuzela et al.
(96).
Materials
All chemicals were analytical reagent grade. Organic
14solvents were redistilled before use. C-DCCD was
prepared by Dr. P.A. Haarthoon (150). Cycloheximide and
3chloramphenicol were purchased from Sigma. H-leucine 
and ^H-Chlorella hydrolysate was purchased from the 
Radiochemical Centre, Amersham.
2.3- Results
Effect of DCCD on partial reactions
ADP stimulated respiration in rat liver mitochondria 
is inhibited by DCCD at 5nmoles/mg of protein (Fig. 2.1). 
The ATP driven reduction of NAD by succinate catalysed 
by rat liver submitochondrial particles is 90% inhibited 
by DCCD at 1.4nmoles/mg protein as illustrated in Fig. 2.2. 
The results presented in Fig. 2.3 show the effect of DCCD 
on the energy linked nicotinamide nucleotide transhydrogen- 
ase driven by ATP in rat liver submitochondrial particles. 
As found by Roberton (139) in beef heart mitochondria, 
higher concentrations of DCCD are required to inhibit this 
reaction than either the ATPase or ATP driven reduction of 
NAD by succinate. Transhydrogenase is maximally inhibited
p +by 3nmoles/mg protein, while the Mg ATPase in submito­
chondrial particles is inhibited by 1nmole/mg protein, as 
shown in Fig. 2.5. The ATPase reaction in rat liver 
mitochondria requires 10nmoles DCCD/mg protein for 
maximal inhibition.
Binding of  ^^ C DCCD
y\ ¿1The binding of C DCCD to rat liver submitochondrial
1?
Fig 2.1
FIGURE 2.1.
Rat liver mitochondria (4mg) were incubated 
with (A) or without (B) 20 nmoles DCCD in a Clarke 
oxygen electrode for 15 minutes at 30°C. (Succinate* 
rotenone), ADP and DNP were added where indicated.
Fig 2.2
INHIBITION OF ATP DRIVEN REDUCTION OF NAD BY 
SUCCINATE
[Deco] nmole/mg protein
FIGURE 2.2.
Rat liver submitochondrial particles v;ere 
incubated with varying amounts of DCCD at 0°C for 18 
hours. 1mg SMP was assayed according to the method of 
Low and Vallin (14?) as modified by Beechey (149).
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Fig 2.3
FIGURE 2.3. '
Rat liver submitochondrial particles were 
incubated with varying amounts of DCCD at 0°C for 18 
hours. 1mg SMP was assayed by the method of 
Danielson and Ernster (14-8) as modified by Beechey (149).
INHIBITION OF Mg2+ATPase IN RAT LIVER MITOCHONDRIA
[d c c d ] nmole/mg
FIGURE 2.4.
Rat liver mitochondria were incubated with 
varying amounts of DCCD at 0 C for 18 hours. 100^g 
mitochondria were assayed for ATPase activity by the 
method of Pullman (146).
Fig 2.5
INHIBITION OF M ij2+ ATPase IN SUBMITOCHONDniAL PARTICLES
FIGURE 2.5-
Rat liver submitochondrial particles were 
incubated with varying amounts of DCCD at 0°C for 18 
hours. 100/jg submitochondrial particles were assayed 
for ATPase activity by the method of Pullman (146).
00
accompanied by a corresponding difference in 1^ C DCCD binding, as shown 
in Table 2.1. Maximum binding of C DCCD occurs at 
less than 1nmole/mg protein, at which concentration 
approximately 70% of the applied counts are covalently 
bound. In agreement with the findings of Beechey et_ al. 
(138), the tightly bound counts are not removed by 
repeated washing, even when phospholipid is included in 
the washing procedure. In contrast, only 10% of the 
applied DCCD was irreversibly bound to intact mitochondria, 
90% being removed in three washes. The binding of DCCD 
to mitochondria is shown in Fig. 2.6.
A  ¿1Preparation of C-DCCD binding proteolioid
^C-DCCD bound to rat liver mitochondria was
14irreversibly bound. Elecbrophorosis of C—DCCD treated
mitochondria in SDS polyacrylamide gels gives two bands 
containing radioactivity as shown in Fig. 2.7* The two 
bands have relative mobilities (with respect to bromo- 
phenol blue tracking dye) of 1.16 and 1.0, with a
14possibility of a third peak at 0.69. Extraction of C-
DCCD treated mitochondria with chloroform/methanol (2:1 v/v)
removes all of the radioactivity as shown in Table 2.2.,
but only half the protein. Most of the protein may be
removed from the extract by washing with 0.2 volumes of
14water, with negligible diminution of the C content. 
Precipitation of the extracted proteolipid by cold ether 
results in loss of about half of the counts into the 
supernatant in contrast to the findings of Cattell et al. 
(78) in beef heart mitochondria. Polyacrylamide gel 
electrophoresis of the ether precipitated proteolipid in
TABLE 2.1. Binding of "^C DCCD to rat liver subroitochondrial
partIcles
Concentration of DCCD
(nmoles/mg) l+C (dpm) dpm Bound %  Bound
1.70 513,680 213,218 65.8
0.27 34,573 23,318 68.0
SMP were incubated with ^^C DCCD at 0 - 4°C for 18 hours 
in 250mM Sucrose/1 OmM Tris-sulphateAmM Magnesium sulphate/ 
1mM ATP/1mM Succinate, pH 7.4. Treated particles vie re 
washed in 250mM Sucrose/10mM Tris-sulphate, pH 7.4.
Samples were counted in Toluene/Triton X-100/Butyl PBD.
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Fig 2.G
BINDING OF 14C DCCD TO RAT LIVER MITOCHONDRIA
DCCD applied nmole/nig
FIGURE 2.6.
'^C DCCD was incubated with 2rag 
mitochondrial protein at 0°C for 18 hours in 5ml 
250mM Sucrose, 10mM Tris-acetate pH 7.5. The 
mitochondria were centrifuged at 14,000^ and the 
radioactivity in the pellet determined by liquid 
scintillation in triton/toluene/butyl PBD.
SDS POLYACRYLAMIDE GEL ELECTROPHORESIS 
RAT LIVER M I T O C HONDRIA
Fig 2.7
FIGURE 2.7. A hC DCCD was incubated with rat liver 
submitochondrial particles at 1nmole/mg for 18 hours 
at 0°C. The particles were washed three times and 
dissolved at 1mg/ml in 3% SDS, 5% mercaptoethanol,
100mM phosphate pH 10 by boiling for 2 minutes. 150pg 
of solubilised SMP were electrophoresed on 7-5% poly­
acrylamide gels as described by Weber and Osbourne 
(143). Gels were sliced into 1mm sections and 
dissolved in 1ml 6% hydrogen peroxide at 60°C. 
Radioactivity was determined by liquid scintillation 
in triton/toluene/butyl PBD.
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TABLE 2.2. Purification of proteolipid
Sample DPM DPM/mg protein %14c :% Protein DCCD/mg
Mitochondria 576,714 16,684 100 100 2.5
Chloroform/
Methanol
extract
407,160 56,484 108 49 5.6
Washed
Extract 341,752 59,956 91 25 9.2
Ether
Precipitate 105,293 59,024 28 8 9.0
Ether
supernatant 152,500 55,888 40 20 5-2
Purification of DCCD binding proteolipid, according 
to the method of Cattell et al., from rat liver mitochondria. 
Details given in the text.
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SDS shows that the C migrates in two band*- „^th
mobilities of 0.95 and 0.68 as shown in Fig. 2.8.
Electrophoresis of standard proteins (cytochrome c,
pyruvate kinase, ribonucléase and lactic dehydrogenase)
shows that these mobilities correspond to molecular weights
of 31,000 and 11,000 respectively. The front running
band with a mobility of 1.16 has disappeared and may
correspond to the radioactivity remaining in the ether
supernatant. Thin layer chromatography of the chloroform
14-methanol extracts from C-DCCD treated mitochondria shows 
14that the C labelled material is roughly divided into
two equal parts, a ninhydrin staining portion which remains
at the origin, and one which does not stain with ninhydrin
and migrates in Benzene/Ethyl Acetate (9:1) on Alumina
plates. Thin layer chromatography of the precipitate
and supernatant at the ether precipitation step shows that
only this migrating band remains in the supernatant and
that the ninhydrin staining, non-migrating portion only
is found in the precipitate. Thin layer chromatograms
of the ether supernatant with DCCD and DCU standards are
shown in Fig. 2.9. The radiolabel is not associated with phospholipid 
as shown by chroniatogra;hy with DGCD labelled standards.
Amino Acid Incorporation
Amino acid incorporation in vitro by the method of 
Beattie (84), was shown to be substantially free from 
bacterial contamination, less than 500 bacteria per ml 
of incubation mixture being routinely found by viable 
count. The incorporation had only a very slight lag 
phase, as illustrated in the time course of incorporation 
in Fig. 2.10, ixidicating negligible contribution by
"14
ELECTROPHORESIS OF ’’C DCCD-FROTEOLiPiu
FIGURE 2 .8 .
14C DCCD was incubated with rat liver sub- 
mitochondrial particles at 1nmole/mg for 18 hours at 0°C.
The particles were washed three times and proteolipid 
prepared by the method of Cattell ejt _al. (70). Proteolipid 
was loaded onto the gels at 150/jg/gel and run according to 
Weber and Osbourne (143). Gels were sliced and counted 
as described in Methods.
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Fig 2.9
THIN LAYER C H R O M A T O G R A P H Y  OF ETHER S U P E R N A T A N T
distance (inches)
FIGURE 2.9.
DCCD was incubated with rat liver sub- 
mitochondrial oarticles at 1nmole/mg for 18 hours at 0°C. 
Proteolipid was prepared as described by Cattell et al. (78). 
Radioactivity remaining in the supernatant after ether 
precipitation of proteolipid was run on aluminium oxide TLG 
plates in Benzene/Ethyl acetate (9:1 v/v).
A Supernatant after ether precipitation of proteolipid 
B Standards, DCCD (Rf 0.9) and DCU (Rf 0.36).
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A M I N O  ACID INCORPORATION TIME COURSE
Fig 2.10
FIGURE 2.10. T.Incorporation of "rl-amino acids into rat 
liver mitochondria in vitro was performed by the method __ 
of Beattie (8h). Aliquots of the incorporation medium 
were removed at the times shown and incorporation 
terminated by addition of an equal volume of 10% TCA.
The TCA precipitate was washed with cold amino acids 
(5mM) and radioactivity determined by liquid scintillation 
in triton/toluene/butyl PBD.
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bacteria to the uptake of amino acids. The incorporation 
of the amino acid mixture into mitochondria was found 
to be chloramphenicol sensitive and cycloheximide resist­
ant as shown by the data in Table 2.J. An attempt to 
identify the products of mitochondrial protein synthesis 
in vitro is illustrated in Fig. 2.11. Electrophoresis 
of labelled rat liver mitochondria in SDS-polyacrylamide 
gels did not give a clear pattern of distinct bands.
The high background level of radioactivity and the high 
rate of incorporation (as found by Beattie (84)), 
indicates that the amino acid uptake is due at least in 
part to a non-specific binding of certain amino acids to 
existing mitochondrial protein as described by Hochberg 
(151). It is possible however, to determine the range 
of molecular weights of the mitochondrial products by 
comparison of the bands with standard markers. It can 
be seen that the majority of the products lie in the 
20 - ¿15,000 dalton range with some incorporation into 
lower molecular weight proteins, in agreement with the 
results of Beattie (94). It can be seen in Table 2.4 that 
20% of the label could be extracted from the labelled 
mitochondria by chloroform/methanol (2:1) under the same 
conditions as preparation of the DCCD-binding proteo- 
lipid. In an attempt to overcome the problems of both
bacterial contamination and non-specific binding, the 
in vivo incorporation of leucine into cycloheximide 
treated rats was studied. Rats were injected inter- 
peritoneally with cycloheximide to inhibit cytoplasmic 
protein synthesis, followed by injection of 7mCi II
. A •
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TABLE 2.5. Inhibitor sensitive Incorporation of amino
acids
System Dpm/mg Protein
Normal 25,153
plus Cycloheximide 19,609
plus chloramphenicol 2,694
Stopped at zero time 299
Sterile (500 - 400 bacteria/ml) mitochondria were 
incubated at 50°C in a shaking water bath. Incorporation 
medium according to Beattie (34) contained 50mM Tris- 
chloride/10mM Sodium phosphate/154mM potassium chloride/ 
5mM Magnesium chloride/1 OmM Succinate/2mM ADP/2mM EDTA, 
pH 7.2. Mitochondria were added to 1mg/ml. Chloram­
phenicol concentration was 1^M, cycloheximide 1C^ jM.
rr: ~ on 4Sf
POLYACRYLAMIDE GEL ELECTROPHORESIS;RAT LIVER
MITOCHONDRIA
FIGURE 2.11. T.Incorporation of H amino acids into rat liver 
mitochondria in the presence of cycloheximide was performed 
as described by Beattie (84). Incorporation was terminated by
addition of an equal volume of 10% TCA. The TCA precipitate 
was washed with cold amino acids (5mM, each amino acid) and 
dissolved in 3% SDS, 3% raercaptoethanol, 100mM phosphate 
buffer pH 10. Polyacrylamide gel electrophoresis was performed 
by the method of Weber and Osbourne (143). Gel slices (1mm) 
were dissolved in 1ml 6% hydrogen peroxide and counted in 9ml 
triton/toluene/butyl PBD scintillant.
50
TABLE 2.A . Chloroform-methanol extraction of roitochond-
rially synthesised protein
Sample DPM
Mitochondria 230,435
Chloroform/
methanol
extract
30,132
% 14C
100
2 1 . 8
Amino acids were incorporated into sterile rat liver 
mitochondria as described by Beattie (84) in the presence of 
1C^ iM cycloheximide. Particles were washed with cold amino 
acids (5mM in 250raM sucrose) and extracted with chloroform- 
methanol (2:1 v/v) as described by Cattell et al. (78).
tr . A n
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leucine/Kg body vjeight. A 'cold' leucine chase was
employed to dilute non-incorporated label and complete
partially synthesised peptides. Mitochondria prepared
from rats treated in this manner showed a high level
of incorporation of tritium as shown in Table 2.5-
Electrophoresis of the mitochondrial protein in SDS-
polyacrylamide gels shows that the major product, in
contrast to the products of the in vitro system, is a
low molecular weight protein with a relative mobility
of 1.0 (Fig. 2.12). The molecular weight of the protein
may be calculated to be approximately 10,000 daltons.
Extraction of the mitochondria with chloroform/methanol
(2:1 v/v) under the same conditions as in the preparation
of the DCCD binding proteolipid removes 20% of the
counts (Table 2.5). Electrophoresis of the extracted
membranes in SDS-polyacrylamide gels shows that the low
molecular weight protein has disappeared, and only the
proteins with molecular weights in the range 52,000 -
80,000 daltons remain as shown in Fig. 2.15. In order
to determine the identity of the low molecular weight
peptides found in these preparations, rat liver mito-
*chondria were labelled in vitro with ^H-leucine in the 
presence of cycloheximide. Incubation of submitochondrial 
particles, derived from labelled mitochondria, with 
1^C DCCD resulted in binding of 70% of the DCCD. Poly­
acrylamide gel electrophoresis of the double labelled 
submitochondrial particles shows that a peptide with a 
molecular weight of 10,000 daltons is labelled with both 
and ^ C  as illustrated in Fig. 2.1h.
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Ta b l e 2.5. Chloroform-methanol extraction of mitochondrially
synthesised protein
Protein
(mg)
* cpm
%
cpm/mg
SMP 40 364,000 9,100
Chloroform-
methanol
extract
16 73,000 4,600
A • 300g Wistar rat was injected with 20mg cycloheximide. 
15 minutes later 2mCi leucine were injected inter- 
peritoneally. After two hours the rat was injected with
cold leucine and killed. Rat liver mitochondria were 
prepared as described in Methods. Chloroform-methanol 
extraction was performed as described by Cattell jet al.
(78).
Fig 2.12
ELECTROPHORESIS (RAT LIVER MITOCHONDRIA)
SLICE N°
FIGURE 2.12. 7.Incorporation of H leucine into rat liver 
mitochondria in the presence of cycloheximide was performed by 
the method of Kuzela (96). Submitochondrial particles were 
dissolved in 3% SDS, 5% mercaptoethanol, 100mM phosphate 
buffer pH 10. Gel electrophoresis was performed according 
to Weber and Osbourne (1A3) 1mM gel slices were dissolved in 
1ml 6% hydrogen peroxide and counted in 9 ml triton/toluene/ 
butyl PBD scintillation cocktail.
FIGURE 2.15
5Incorporation of H leucine into rat liver mitochondria 
was performed according to Kuzela (96). Chloroform- 
methanol extraction of submitochondrial particles was 
carried out as described by Cattell (78). Chloroform- 
methanol extracted narticles were dissolved in 3% SDS, 
5% mercaptoethanol, 100mM phosphate pH 10. Electro­
phoresis was carried out as described by Weber and 
Osbourne (143), gel slices were dissolved in 6% 
hydrogen peroxide.
D 
PI
VI
Fig 2.13
CHLOROFORM METHANOL EXTRACTED PARTICLES
H Ì
Fig. 2.14.
Double labelling of the DGCD binding protein
Incorporation of leucine in the presence of cyclo- 
heximide into rat liver mitochondria was performed as 
described by Kuzela (96). Submitochondrial particles were 
prepared from the washed mitochondria as described in Methods. 
14C DCCD was incubated with 5H-submitochondrial particles 
at 0°C for 18 hours. The washed SMP were dissolved in 3% 
SDS, 3% mercaotoethanol, 100mM phosphate pH 8.5* Electro­
phoresis in 7.5% polyacrylamide pels was performed as 
described by Weber and Osbourne (143). 1mM gel slices were 
dissolved in 1ml 6% hydrogen peroxide and counted by liquid 
scintillation in 9ml triton/toluene/butyl PBD. Spillover 
of r+C into 'H was corrected for by reference to known
standards.
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2.4 Discussion
DCCD inhibits ATP dependant reactions in rat liver 
mitochondrial particles at levels comparable with those 
found for electron transfer particles from beef heart 
(138). The ATPase in intact mitochondria, however, 
requires ten times the concentration of DCCD as submito- 
chondrial particles. A tenfold increase in the sensitivity 
is the opposite effect to that expected, as the site of 
action would be expected to be in the membrane (1 3 9) and 
thus be concentrated by preparation of submitochondrial 
particles. One mechanism explaining this phenomenon is 
a permeability barrier to DCCD at the inner mitochondrial 
membrane. DCCD is a very lipophilic molecule and as 
such should pass through the inner membrane easily. It 
has been shown that the potency of carbodiimides is 
related to their hydrophobicity (101) and that DCCD is 
one of the most effective carbodiimides inhibiting 
oxidative phosphorylation in bacteria. It should be 
noted, however, that only 10% of the applied DCCD is 
strongly bound to mitochondria, while 70% is bound in 
submitochondrial particles, which have been evoked by 
sonication. It is possible therefore that a permeability 
barrier to DCCD does exist and that the site of action is 
accessible only from the inner side of the inner mito­
chondrial membrane. Alternatively, the binding site 
may be partially blocked by some other component in intact 
mitochondria and not in vesicles prepared by sonic 
disruption.
Two components binding DCCD have been found in rat
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liver mitochondria. This does not conflict with the
results obtained by Cattell efb _al. (78) and Broughall
(152) in beef heart mitochondria. Cattell et al.
recovered 43% of C-DCCD in the purification of DCCD-
binding proteolipid but give no details of the remaining
57% 14C. Broughall recovered 3^% of the DCCD as
proteolipid, but found that 27% of the counts remained
in the supernatant after ether precipitation. Both the
binding data and the results of proteolipid preparation
indicate tv/o binding sites for DCCD in rat liver mito-
14chondria. Analysis of the binding of C DCCD by
Scatchard plot (Fig. 2.14) gives two straight lines
indicating two binding sites, a tightly binding site
(K^ = 7-8 x 10~^M) and a loose binding site (K^ = 1 .25
x 10-^M). Examination of SDS-polyacrylamide gels of 
14C DCCD treated mitochondria shows three bands containing
14 ,C, of which the front running band (relative mobility
1.16) is absent in similar gels of proteolipid precipitated
by ether, as shown in Figs. 2.7 and 2.8. Thin layer
chromatography of the proteolipid fraction precipitated
by cold ether shows that there is only one band, staining
with ninhydrin, which remains at the origin, but two bands
are found in chromatograms of the chloroform/methanol
extract. The second band, is also found in chromatograms
of the supernatant remaining after ether precipitation of
the proteolipid, and has the same relative mobility (0.85)
as free DCCD. The second cOWBUiwut binding DCCD is
probably mitochondrial lipid; in aqueous preparations the
DCCD is bound in lipid vesicles, but in organic solvents,
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Fig 2.15
BINDING OF 14C DCCD TO MITOCHONDRIAL ATCHARD PLOT
FIGURE 2.15* A hC DCCD was incubated with 2mg mitochondrial 
protein at 0°C for 18 hours in 5ml 250mM Sucrose, 10mM 
Tris-acetate pH 7.5. The mitochondria were centrifuged at 
14,OOOg and the radioactivity in the pellet determined 
by liquid scintillation in triton/toluene/butyl PBD.
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the DCCD is freed from the lipid.
DCCD bound to the proteolipid fraction is usually 
assumed to be bound covalently, but the data presented in 
Fig. 2.15 suggests that this is not so, although the 
equilibrium in the reaction
Proteolipid + DCCD «---» proteolipid-DCCD
lies far to the right. From the intercepts in Fig. 2.15, 
it can be calculated that there are 0.7 nmoles of DCCD 
binding protein/mg mitochondrial protein. This is in 
good agreement with the findings of Beechey (71)- 
Similarly it suggests that there are 2 - 5  molecules of 
DCCD binding protein per ATPase molecule. The molecular 
weight of the DCCD binding proteolipid is in the range 
10 - 11,000 daltons, but a small associated peak is found 
with a molecular weight of 51,500 daltons.
The molecular weight of the DCCD binding protein from 
beef heart is approximately 10,000 daltons (159), while 
the proteolipid extracted from yeast OS-ATPase by 
Taagoloff (57) has a molecular weight of 8,000 daltons 
Tzagolofi has also shown that the OS-ATPase proteolipid 
migrates with an apparent molecular weight of 45,000 
in SDS-gels, and treatment with base or organic solvents 
causes it to migrate with a molecular weight of 8,000. 
Possibly the 51,500 dalton protein in the rat liver 
proteolipid corresponds to this 45,000 dalton product in 
the yeast OS-ATPase complex, although it is not affected 
by organic solvents. The effect of base on the 5^,500 
d.alton protein cannot be determined as the carbodiimide- 
protein bond is base labile.
I,'
The biogenesis of the chloroform extractable
proteolipids has been examined both in vitro and in vivo.
In the former case, chloramphenicol sensitive incorporation
of amino acids was mainly into proteins with molecular
weights of 20 - 45,000 daltons, in agreement with the
results obtained by Beattie (94). The major peak in
the rather diffuse band covering this molecular weight
range lies at about 39,000 (Beattie 40,000) daltons.
Burke and Beattie have shown that the lyophilisation of
rat liver mitochondria converts this 40,000 dalton band
into a iO - 14,000 dalton band (95)* It is probable
that this corresponds to both the 31,500 dalton band found 
14in C-DCCD labelled proteolipid preparations and to the 
45,000 dalton band found by Tzagoloff (57, 76). 20% of
the radioactive label could be removed by chloroform/ 
methanol, but SDS-polyacrylamide gel electrophoresis of 
the extract was not possible as the quantities used did 
not give a discernable ether precipitate.
Gels of mitochondria labelled in vivo in the presence 
of cycloheximide indicate that the major product of mito­
chondrial protein synthesis is a protein with a molecular 
weight of 10,000 daltons, in agreement with the results 
of Kuzela (96). Chloroform/methanol extraction of these
mitochondria removes about 20% of the radiolabel, but 
electrophoresis of the extract was not possible as for the 
in vivo experiment. Electrophoresis of the extracted 
membranes, however, shows that the main product of mito­
chondrial protein synthesis is extracted from the membrane, 
only bands with molecular weights in excess of 46,000
daltons remaining.
Polyacrylamide gel electrophoresis of suhmitochondrial
•5particles, labelled with leucine in vivo, and treated 
14with C DCCD, show that the chloroform methanol soluble 
10,000 molecular weight proteins which are the major 
product in mitochondrial biogenesis, and the binding site 
of DCCD, comigrate in the presence of SDS. It would 
seem reasonable, on the basis of the similarity between 
the major product of protein synthesis and the DCCD binding 
protein, namely their solubility in chloroform methanol 
and co-migration in SDS-gels, that the two proteins are 
in fact identical.
CHAPTER % SOLVENT EXTRACTION OF MITOCHONDRIA
3.1. Introduction
The effect of lipids on the properties of membrane 
bound enzymes is well documented (153). The delipidation 
of membrane bound enzymes has been effected by such diverse 
methods as extraction with organic solvents, detergents, 
bile salts and treatment with lipolytic enzymes (153). 
Extraction of mitochondria with organic solvents has been 
shown to result in the loss of respiration or phosphoryl­
ation (153 - 155). Lenaz and co-workers have shown that 
extraction of mitochondrial membranes with alcohols has a 
profound effect on the functioning of oxidative phosphor­
ylation (154, 155). The interaction of phospholipids 
with lipid depleted membranes has been shown to be inhibited 
by alcohols (156). Alcohols have also been shown to 
extract phospholipids from beef heart mitochondria (157). 
Enzymic activities damaged by such extraction include 
succinoxidase and ATPase, but at low concentrations of 
alcohol the ATPase is rendered oligomycin insensitive (155)- 
The effect of alcohols on these enzyjg£s is not reversed by 
addition of phospholipid (158), and has been shown to be 
related to the hydrophobicity of the alcohol used (155).
Diethyl ether has also been used for delipidation of 
the ATPase and appears to be similar to long chain 
alcohols in that oligomycin insensitivity may be induced 
(155, 159)» but relatively little phospholipid may be 
removed from beef heart mitochondria by ether extraction 
(157), and the ATPase activity is not decreased (159).
1, *,t 1
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Broughall at al_. have shown that ether extraction renders 
the ATPase insensitive to venturicidin and DCCD.
3.2. Methods and Materials
Preparation of mitochondria and submitochondrial particles
Rat liver mitochondria were prepared by the method of 
Johnson and Lardy (160). Yeast mitochondria were 
prepared as described by Tzagoloff (41), from a commercially 
available strain of Saccharomyces cerevisiae. Insect 
flight muscle mitochondria were prepared by the method of 
Van den Berg (161). Beef heart mitochondria were prepared 
by the method of Sanadi and Fluharty (162). Submito- 
chondrial particles were prepared by sonic disruption of 
mitochondria in an M.S.E. sonicator, and sedimented by 
centrifugation at 100,000g.
Assay of enzymic activities and extraction with organic 
solvents
ATPase activity was measured as described by Pullman 
et al. (146), or by the method of Wakabayashi and Gunge 
(163). Phosphate estimation was performed as described 
by Fiske and SubbaRow (164). Particles were preincubated 
with inhibitors for 5 minutes at 30°C, except for NCCD and 
DCCD which were incubated at 0°C for 18 hours.
Extraction of particles with organic solvents for ATPase 
assays were performed as described by Broughall _et al.
(159), the solvent being removed by aspiration and nitrogen 
blown through the suspension. In titrations of the 
organic solvents, the solvent was added directly to the 
mitochondrial suspension and was not removed. All extract-
» ;
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ions were performed at 0°C. Protein was estimated by 
the biuret method of Gornall ejb al. (141).
Electron Spin Resonance
E.S.R. spectra were obtained using a Decca Radar X1 
with a Newport Instruments 7 inch magnet. Samples were 
run in sealed glass capillary pipettes. Samples were 
incubated with the spin probe NCCD at 0°C for 18 hours, 
and with stearic acid derivatives for 5 minutes at 0°C.
The NCCD treated mitochondrial preparations were washed 
four times in 50 volumes of sucrose-tris pH 7.5*
Potassium ferricyanide (1m M) was added to all buffers to 
prevent reduction of the nitroxide spin probe.
Materials
Ossamycin and peliomycin were obtained from NCI via 
Dr. H. Schmidtz. Venturicidin was a gift from Dr. I. 
Fleming (Glaxo Laboratories Ltd.). Trialkyl tin chlorides 
and DCCD were obtained from British Drug Houses Ltd. 
Oligomycin was purchased from Sigma Chemical Co. Ltd. 
and was a mixture of oligomycins A(15%) and B (85%).
14C DCCD was a gift from Prof. R.B. Beechey (Shell Research
11iLtd.) and Sn triethyl tin was purchased from the 
Radiochemical Centre (Amersham). NCCD was synthesised by 
P. Iannou. All organic solvents were redistilled before 
use, all other reagents were analytical grade.
Counting
A A A Z " 4C and Sn were counted in a Packard Tricarb 
Scintillation counter in a Triton X-100/Toluene/butyl PBD
A A -2
scintillation cocktail (144). ?Sn was counted as its
0/
Indium decay product (165).
5*5. Results --
Extraction of particles with organic solvents
It can be seen from the data presented in Table 5.1 
that olivomycin sensitivity is destroyed by extraction 
of beef heart submitochondrial particles with a variety 
of organic solvents. At high concentrations of methyl 
acetate the ATPase activity is destroyed, and some inhibition 
of the ATPase is found with carbon tetrachloride but 
diethyl ether has no inhibitory effect on the ATPase 
activity. Extraction of submitochondrial particles from 
a variety of sources leads to loss of ATPase inhibition 
by rutamycin, oligomycin, venturicidin, peliomycin, ossa- 
mycin, triethyl tin, DCCD and NCCD but not aurovertin B.
This phenomenon has been demonstrated in submitochondrial 
particles derived from Saccharomyces cerevisiae (Table 
3.2), beef heart (Table 3.5) and Sarcoohaga barbata flight 
muscle (Table 3.z0.
Effect of ether extraction on inhibitor binding
Table 3.6 illustrates the inextractability of the 
binding site for DCCD. Particles extracted with diethyl 
ether will still bind ^C-DCCD, and no protein is removed 
from the particles in the extraction procedure. Invest­
igation of the binding of 11^Sn Triethyl tin shows that 
there is no difference in the binding of the inhibitor to 
the high affinity site (Fig. 3.1). There is a 30% decrease 
in the binding of the triethyl tin at higher concentrations
,W ■’ |; ;fcTT \
TABLE 3.1 Extraction of Beef Heart submitochondrial
particles
Solvent
ATPase y  mole/min/mg 
+ oligomycin - oligomycin
_ 0.19 2.15
Diethyl ether 2.03 2.19
Methyl acetate 2.06 1.98
Carbon tetrachloride oCO• 1.76
ATPase assays were performed according to W'akabayashi 
and Gunge (163), solvent extraction was performed as 
described by Broughall (159).
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TABLE 3.2. Insensitivity of ether extracted YETp to
various inhibitors
Inhibitor and -1ATPase pmole min mg protein
concentration Control Et 2^-Y gfpp
- 1.10 1.15
oligomycin
ip e/mg 0.65
o.yo
rutamycin
1u g/mg 0.54 1 .ot>
venturicidin
1p g/mg 0.36
oo•
ATPase activity was measured by the method of Pullman 
(146). Ether extraction was performed as described by 
Broughall (159).
r\
TABLE 3.3. Ether extraction of ETP^ and removal of
inhibitor sensitivity
Inhibitor and
_1ATPase p moles min mg protein
Concentration Control ETP Ether ETP
A 1.52 1.03
oligomycin 16.6}Jg/mg 0.15 0.95
DCCD 2nmoles/mg 0.15 1.52
DCCD 2nmoles/mg + 
oligomycin 16.6/Jg/mg - 1.57
B 1.52 0.58
rutamycin 16.6pg/mg 0.34 0.49
ossamycin 16.6)Jg/mg 0.25 0.44
peliomycin 16.6^ig/mg 0.22 0.49
venturicidin 16.6^ig/mg 0.15 0.74
C 0.83 0.69
Triethyl tin 10nmoles/mg 0.09 0.85
D 0.98 0.58
Aurovertin B 16.6;jg/mg 0.49 0.27
E 0.65 0.54
NCCD 6nmoles/mg 0.38 0.49
ATPase activity was measured by the method of Pullman 
(146). Ether extraction was performed as described by 
Broughall (159).
ATPase activity in Ether-ETP is cold Ibile,hence the specific activity 
in B is lower than the control.Similarly, the apparent stimul ation in 
3 by venturicidin, and by triethyl tin in C, in due to these assays being 
performed before the control.
T ABLE 3.A. Insensitivity of ether extracted ATPase to
various inhibitors
Inhibitor and
concentration _1ATPase /j mole min mg-  ^ prot
Control SFiP Et20-SI1P
_ 1.19 1.13
ossamycin 16.4pg/mg 0.24 1.06
oligomycin 16.4/jg/mg 0.32 1.03
peliomycin 16.4pg/mg 0.32 1.16
venturicidin 16.4/jg/mg 0.42 1.24
triethyl tin 16.4nmoles/mg 0.42 1.16
ATPase activity was measured by the method of Pullman 
(146). S. barbata flight muscle SMP were extracted with 
ether at 0°C according to Broughall (159).
V / I '
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TABLE 3.5. Reactivation of DCCD inhibited <\TPase
. --1ATPase pmoles m m _^lmg ' protein
- oligomycin + oligomycin
Submitochondrial
particles (SEP) 1.19 0.32
DCCD-SMP 0.40 -
SMP(EtpO) 1.13 1.03
DCCD-SMP(EtpO) 1.16 -
Submitochondrial particles from S. barbata flight 
muscle were preincubated with DCCD at Inmole DCCD/mg 
protein at 0°C for 18 hours (DCCD-SMP). Ether extraction 
was performed according to Broughall (159) to give 
SMP(Et20)* ATPase assays were performed by the method of 
Pullman (146).
TABLE 3-6. Binding of 1'+C DCCD to ETPH(Et20)
Submitochondrial Particles % 14C bound
ETPh 78
ETPH(Et20) 75
^/+DCCD was incubated with POrag mitochondrial particles 
at 1nmole/mg at 0°C for 18 hours. The particles were 
washed three times in 30ml ?50mM Sucrose 10mM Tris-acetate 
pH 7.5. Radioactivity was measured by liquid 
scintillation in Triton/toluene/butyl PBD. Ether 
extraction was oerformed as described by Broughall (159).
Fig 3.1
EFFECT OF DIETHYL ETHER ON113Sn TET BINDING IN YETP.
TET nmole/mg protein
FIGURE 3.1.
Yeast submitochondrial particles (2ms) vrere 
incubated at 0°C with varying amounts of Sn triethyl 
tin in 5ml 250mM Sucrose, 10mM Tris-acetate pH 7.5.
After 30 minutes, the susoension was centrifuged and the 
pellet dissolved in 1ml 2% triton X-100. Radioactivity 
was measured in a Packard Tricarb scintillation counter.
L ETP O— O YE1’P (Et20)
-% w i;
although this is not found at the lowest concentrations , 
indicating a modification or extraction of the low affinity site.
Lipids extracted by diethyl ether
Separation of the ether extracts from beef heart, 
rat liver and yeast submitochondrial particles is shown 
in Fig. 3.2. It can be seen that only two lipid classes 
are found in all of the extracts, namely phospholipids and 
fatty acids. More lipid is removed from yeast particles 
than from rat liver and beef heart. Analysis of the 
phospholipid fraction by thin layer chromatography shows 
that phosphatidyl choline is removed from mammalian 
mitochondria, but cardiolipin is removed from yeast mito­
chondria as illustrated in Fig. 3.3. Gas liquid chromato­
graphy of the methyl esters of the fatty acids removed by
ether extraction is illustrated in Fig. 3.4. Hydrocarbons are 
also extracted by diethyl ether.
Properties of the ATPase of ether extracted particles
In addition to the loss of inhibitor sensitivity, 
other properties of the membrane bound ATPase are altered 
by extraction with organic solvents. Extraction with 
methyl acetate at concentrations over 25% leads to total 
loss of activity. Extraction with all of the organic 
solvents used leads to cold lability of the ATPase. No 
decrease in activity is found with diethyl ether. The 
pH profile of ATPase in normal and ether extracted particles 
is shown in Fig. 3.5« It can be seen that no relative 
change in activity occurs at either the pH 9-5 or pH 
6.5 maxima.
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FIGURE 3.2.
TLC was performed on 0.^ >Tnm Silica Gel plates. 
Solvent was petroleum ether/diethyl ether/acetic acid 
(90:10:1 v/v). Spots were visualised with iodine vapour. 
Dashed spots are very faint.
A — tetradecane B — triolein C — palmitic acid
D - lecithin E - Ether extract from beef heart SMP
F - Ether extract from yeast SMP 
G - Ether extract from rat liver SMP
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FIGURE 3.3.
TLC was performed on Silica Gel N 
(+ 120mg Ammonium sulphate/30g) 0.3mm plates.
Solvent was Chloroform/Methanol/Acetic acid/water 
(50:25:8:1 v/v). Spots were visualised with iodine 
vapour. A - phosphatidyl serine, B - diphosphat- 
idylglycerol, C - phosphatidic acid, D - phosphat- 
idylethanolamine, E - phosphatidylcholine, F - 
Ether extract from beef heart SMP, G - Ether extract 
from yeast SMP, H - Ether extract from rat liver SMP.
FIGURE 3.^.
Fatty acid composition of ether extracts of 
Y and ETP^. Fatty acids are expressed as a oercentageililx n
of the total fatty acids. The fatty acids are denoted 
by the convention number of carbon atoms: number of double 
bonds. Fatty acids were determined as their methyl 
esters as described by Watson et al^ . (186).
A -yeast mitochondria,B _ bovine heart mitochondria
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Fig 3.5
pH DEPENDENCE OF Mg2+ATPase = EFFECT OF DIETHYL ETHER
FIGURE 3-5.
ATPase activity was measured by the 
method of Wakabayashi and Gunge (163)- Ether 
extraction was performed essentially as described by 
Broughall 059) without evanoration of ether with 
nitrogen. O---O  ^ETP’ ®— ® ^ETP
* '  h n i
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The critical concentration of solvent required for loss 
of sensitivity
Titration of the concentration of diethyl ether 
required for loss of inhibitor sensitivity is illustrated 
in Figs. 3.6 to 3.9. It can be readily seen that the 
concentration of ether required for loss of sensitivity is 
12 - 15% in both yeast and beef heart mitochondrial 
particles. This is true for the inhibitors oligomycin, 
triethyl tin and DCCD. Loss of inhibition occurs over a 
very small concentration range: inhibition starts to 
decrease at 10% diethyl ether and is complete at 15%.
Loss of sensitivity to oligomycin and DCCD caused by 
extraction by methyl acetate is shown in Fig. 3-9. 
Inhibition begins to decrease at 15% methyl acetate and is 
complete at 20% methyl acetate.
Electron soin resonance: a probe of membrane fluidity
A nitroxide analogue of the inhibitor DCCD is the 
compound NCCD. The respective structures of NCCD and 
DCCD are shown in Fig. 3-10. The degree of inhibition 
of ATPase in beef heart submitochondrial particles is 
very similar as shown in Fig. 3.11. The E.S.R. spectrum 
of NCCD is shown in Fig. 3. 12. Incubation of the spin 
probe with beef heart submitochondrial particles causes 
a strong degree of immobilisation as shown by the loss of 
structure in the spectrum. The degree of immobilisation 
is so great that it is immposible to determine any of the 
parameters from the E.S.R. spectrum. Extraction with 
diethyl ether does not change the mobility of the probe
>, . • • j--' -- *r CT r
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Fig 3.6
EFFECT OF DIETHYL ETHER ON INHIBITOR SENSITIVITY IN YETP
FIGURE 3.6.
ATPase activity was measured by the 
method of Vakabayashi and Gunge (163). Ether 
extraction was performed essentially as described by 
Broughall (159) without evaporation of ether with 
nitrogen.
O— O Y ^ p  + triethyl tin
A — A  YETp + oligomycin
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Fig 3.7
EFFECT OF DIETHYL ETHER ON INHIBITOR SENSITIVITY IN ETPH
FIGURE 3.7.
A'tfPase activity was measured by the 
method of Wakabayashi and Gunge (163). Ether 
extraction was oerformed essentially as described by 
Broughall (169) without evaooration of ether with 
nitrogen.
O O ETPh + triethyl tin
A — A  ETPh + oligomycin
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Fig 3.8
EFFECT OF DIETHYL ETHER ON DCCD SENSITIVITY IN ETPH
FIGURE 3.8.
ATPase activity was measured by the 
method of Vakabayashi and Gunge (163)- Ether 
extraction vas essentially performed as described by 
Broughall (139). DCCD was incubated with ETP^ for 
18 hours at 0°C, prior to extraction with diethyl 
ether.
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Fig 3.9
EFFECT OF METHYL ACETATE ON INHIBITOR SENSITIVITY
% METHYL ACETATE
FIGURE 3.9.
ATPase activity was measured by tic method 
of Wakabayashi and Gunge (d63). Extraction of Yg^p 
with methyl acetate was performed at 0°C.
o— O  Yetp + olivomycin 
®-- ® YETP + triethyl tin.
1
V
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N =  C
DCCD
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fifi
Inhibition ot heart mitochondrial ATPase by DCCD 
and N C C D
Fig 3.11
Concentration of inhibitors 
(nmoles/ mg protein)
f i g u r e 5.11
ATPase assays were performed according 
to Wakabayashi and Gunge (165). Inhibitors were 
preincubated with ETPR at 0°C for 18 hours.
0— O  DCCD NCCD.
v,,. '.jp.- *r * - *  • . s-r '*■ /» t r
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Fig 3.12
FIGURE 3.12.
A. ESR spectrum of NCCD in 25OmM 
Sucrose lOrnM Tris-acetate pH 7.5-
B. ESR spectrum of NCCD in beef heart mitochondrial 
membranes.
NCCD was incubated with ETPH at 1nmole/mr; mitochondrial 
protein at 0°C for 18 hours. Free NCCD was removed 
by repeated washing with sucrose-tris.
i
i i  )
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as can be seen in Table 3.7. The ratio of the high to
medium field line heights does not alter significantly 
over the range 0-50% ether, indicating no change in the 
rotational mobility of the probe. No estimate of the 
hyperfine splitting is possible because of the extreme 
degree of immobilisation of the probe.
NCCD does not bind strongly to yeast submitochondrial 
la-particles, nor does C-DCCD bind covalently, only about 
3% of the applied inhibitor binding.
Incubation of beef heart submitochondrial particles 
with the 5-N-oxyl-4'-4'-dimethyloxazolidine derivative of 
stearic acid causes a decrease in the freedom of motion 
of the label, as shown in Fig. 3.13. Titration of the 
particles with diethyl ether causes an increase in the 
rotational freedom as shown by a decrease in the hyperfine 
splitting (2T^) and in the ratio of the high to medium 
field line heights as shown in Fig. 2.14. The increase 
in rotational mobility begins at 10% diethyl ether, i.e. 
the same concentration of solvent at which inhibitor 
sensitivity begins to decrease.
3.4. Discussion
Extraction of beef heart mitochondrial particles with a 
variety of organic solvents results in the loss of inhibitor 
sensitivity. Diethyl ether was chosen as the most 
suitable solvent for a variety of reasons; (a) diethyl 
ether is relatively easily removed, (b) no loss of ATPase 
activity is found on extraction with diethyl ether, 
although the ATPase is rendered cold labile as found with
s y r -  *r: }it 1
onUJ
NCCD
TABLE 3.7* Effect of diethyl ether on the mobility of
% Ether A/B
NCCD was incubated with ETPH at 1nmole/mg protein for 
18 hours at 0°C as described by Azzi (179). Diethyl 
ether was added to the concentrations shown and shaken 
on a rotary mixer. ESR spectra were recorded on a 
Decca Radar X1 with a Newport Instruments 7 inch magnet.
)
on
Fig 3.13
FIGURE 3.13.
ESR spectrum of the 5-N-oxyl 4 ’,V 
dimethyloxazolidene derivative of stearic acid incorporated 
into beef heart submitochondrial membranes. For methods 
see text.
v, , . • | n r  ‘ .
MEFFECT OF DIETHYL ETHER ON MOBILITY OF STEARIC ACID
F ig  3.14
FIGURE 3.14.
Ether extraction was performed as 
described by Broughall (139).
©___ q  ratio of high to medium field line heights
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other solvents, (c) it is known that diethyl ether removes 
no protein and relatively little lipid fi-om mitochondrial 
particles (15 7)- Diethyl ether extraction confers 
insensitivity to oligomycin (9), rutamycin (29), ossa- 
mycin (167)» peliomycin (166, 167)» venturicidin (3*0» 
triethyl tin (29, 33), DCCD and NCCD (31, 32) but not 
aurovertin B or Dio-9 (35), as shown by Tables 3.1 to 3.4. 
This insensitivity to inhibitors is independent of the 
source of submitochondrial particles; thus the membrane 
bound ATPases of yeast, insect (Sarconhar^a barbata) flight 
muscle, and beef heart are all rendered inhibitor insensitive 
by diethyl ether extraction. A similar effect upon the 
ATP/Pi exchange has been reported (168). The effect is 
not due to residual solvent, since removal of solvent by 
freeze-drying of extracted submitochondrial particles does 
not reverse the loss of inhibition (169). The insensitivity 
caused by solvent extraction may arise in several ways, 
of which the most likely are shown in Pig. 3.15; (a) a
target lipid may be removed which is responsible for 
transport of the inhibitor to the binding site, (b) there 
may be a conformational change in the ATPase such that the 
inhibitor binding peptide does not interact with the ATPase 
catalytic site, (c) the F^ ATPase may be removed, (d) the 
binding site may be made inaccessible to the inhibitor,
(e) the inhibitor binding site may be extracted.
Mechanism (a) seems improbable considering the variety of 
inhibitors and particles in which the effect can be found. 
Examination of the ether extracts by TLC and GLC, as 
shown in Figs. 3.2 to 3-/+, shows no similarities between
i . | ‘..t *  % • . • i
SOLVENT EXTRACTION
POSSIBLE MECHANISMS FOR LOSS OF INHIBITOR SENSITIVITY
A Inhibited
B Functional separation of inhibitor site 
C Inaccessibility of inhibitor site 
D Extraction of inhibitor site
E Extraction of F1
C
extracts from different submitochondrial particles. In 
this connection, it is interesting that phosphatidylcholine, 
a suggested target lipid for DCCD (170), is removed from 
both rat liver and beef heart particles. However both 
1/,C DCCD and ^^Sn Triethyl tin can be shown to bind to 
ether extracted particles, thus ruling out mechanisms 
(a), (d), and (e).
Mechanism (e) also seems improbable since simultaneous 
extraction of all the inhibitor sites is unlikely; it is 
very likely that the binding sites for oligomycin, 
venturicidin and triethyl tin lie on different peptides 
(114). Moreover, the site of action of DCCD is a proteo- 
lipid which is not extracted by diethyl ether from mito­
chondrial membranes (78). Induction of DCCD sensitivity 
also rules out mechanism (d). Submitochondrial particles 
incubated with DCCD have an irreversibly inhibited ATPase 
and a strongly bound inhibitor. If mechanism (d) is 
operative, then extraction of the DCCD-treated particles 
will have no effect on the inhibited ATPase since the 
DCCD has already bjsen bound to the inhibitor binding site.
If mechanisms (b) and (c) are operative then solvent 
extraction will lead to a reactivation of the inhibited 
ATPase activity. The data in Table 3.5 shows that 
extraction of DCCD treated flight muscle submitochondrial 
particles results in a restoration of the ATPase activity 
to the control level. Similar results have been obtained 
with DCCD and NCCD in beef heart submitochondrial 
particles.
Mechanism (c), the extraction of F^ , would seem
likely from some of the properties of the ether treated 
ATPase: cold lability, insensitivity to oligomycin, 
sensitivity to Dio-9 and aurovertin B. The extraction 
of the catalytic site is probably not the case for 
diethyl ether extraction, although extraction with 
chloroform does operate in this way (171). No protein 
is found in the supernatant after diethyl ether extraction 
(169). No ATPase activity is to be found in the super­
natant after diethyl ether extraction, nor is there a 
decrease in specific activity of the extracted particles, 
other than that due to the cold lability of the ATPase 
(169). This would appear to rule out mechanism (c).
Mechanism (b), the functional separation of the 
inhibitor site from the ATPase, has been suggested by 
Lenaz (155) as the mode of action of short chain alcohols 
on beef heart mitochondrial ATPase. The concentration 
of alcohol required for extraction of phospholipid is much 
higher than that required for loss of oligomycin sensitivity 
(154) and it is suggested that low concentrations of 
alcohols disrupt the lipid bilayer and thus alter the 
conformation of the ATPase complex (155). Lenaz has 
noted a correlation between the effectiveness of the 
alcohols and their chain length (15^). A similar effect 
has been found by Hegyvary (172); the Na+/K+ ATPase of 
the plasma membrane is inhibited by alcohols. This can 
be shown to be due to an increased fluidity of the membrane 
and a disruption of hydronhobic interactions, The concen­
tration of alcohols giving half maximal inhibition of the 
Na+/K+A.TPase may be correlated with their chain length or
the octanol-water partition coefficients (172). Use 
of a nitroxide labelled sterol shows that the hyperfine 
splitting constant decreases at the same concentration 
which causes half maximal inhibition (175). Lenaz has 
shown that n-butanol increases the fluidity of the beef 
heart mitochondrial membrane as measured by the E.S.R. 
spectrum of the 5-, 12-, and 16-N-oxyl 4',4' dimethyl- 
oxazolidine derivatives of stearic acid (154). Similarly, 
the half maximal loss of inhibition induced by diethyl 
ether occurs at about 12% diethyl ether. This critical 
concentration of diethyl ether appears to be the same for 
oligomycin, triethyl tin and DCCD. It is independant of 
the source of the submitochondrial particles. Examination 
of the E.S.R. spectrum of the 5-N-oxyl 4',4' dimethyl- 
oxazolidine derivative of stearic acid shows that the 
fluidity of the membrane increases at this same concen­
tration of diethyl ether. It would seem likely therefore 
that the functional separation of the inhibitor site 
from the ATPase arises from a modification of protein- 
lipid interactions. The hydrophobic interaction of 
membrane proteins with lipids m§.y be extensively modified 
by an increase in the fluidity of the lipid bilayer.
This is supported by the observations of Lenaz (15*0 that 
the activation energy of beef heart mitochondrial ATPase 
is increased three fold by n-butanol, although no data is 
given on the displacement of the break point in Arrhenius 
plots of the ATPase. Also, the ratio of the high to 
middle field line heights of the nitroxide labelled stearic 
acids decrease to the level found in phospholipid
vesicles (154). This ratio tnay he taken as an indication 
of rotational freedom (174).
Prompted by the similarity of the critical concen­
tration of diethyl ether to the solubility of the solvent 
in water, an investigation of the critical concentration 
of other solvent shows that the loss of inhibition and 
the increase in fluidity of the mitochondrial membrane 
occur at the concentration at which the aqueous ohase is 
saturated with solvent. This has been found for diethyl 
ether, carbon tetrachloride, and methyl acetate. Kates 
(1 7 5) has shown that phospholipases in plastids are 
stimulated by diethyl ether, and that maximal stimulation 
is found at the concentration at which the aqueous phase 
is saturated with diethyl ether. While the stimulation 
of phospholipase is not advanced as a possible mechanism 
for the loss of inhibitor sensitivity in mitochondria, the 
suggestion (176) that diethyl ether at saturating concen­
trations causes surface dilution of the closely packed 
molecules at the lipid-water interface may provide reason 
for the increase in membrane fluidity. Lenaz (156) has 
suggested that specific phospholipids are extracted by 
alcohols and ether, labilising protein-lipid bonds in 
the membrane.
The conformation of membrane proteins has been shown 
to be profoundly affected by lipid depletion (153). 
Cunningham has found that ether treatment prevents the 
visualisation of inner membrane spheres by negative staining 
(177). This has been found to be true of other organic 
solvents which cause loss of inhibitor sensitivity (168).
Similarly Kagawa and Racker (58) and Kopaczyk (59) have 
shown that in'oligomycin sensitive ATPase phospholipids 
were essential for oligomycin sensitivity and visual­
isation of inner membrane spheres. Although this would 
appear to support the notion of a conformational change 
in the ATPase, interpretation of negatively stained 
preparations must be made with caution; freeze-etched 
preparations of the matrix face of the inner mitochondrial 
membrane do not display projections corresponding to 
those found by negative staining (178).
Although the change in the ATPase is not sufficient
to cause gross changes in the properties of the ATPase activity.
such as the pH dependance, it was considered possible
that a change in conformation of the DCCD binding protein
might be monitored by use of the spin label analogue
NCCD (179). The nitroxide analogue of DCCD is very
similar (Fig. 5.10) in structure, and the inhibition of
the ATPase activity by NCCD and DCCD is very similar (Fig.
3.11). The E.S.R. spectrum of NCCD bound to beef heart
submitochondrial particles shows that the inhibitor is
bound very strongly to the membrane. Either extraction
of NCCD treated particles removes the inhibition completely,
but this is not due to a change in the mobility of the
NCCD as shown by Table 3.7. However, Azzi et al. (179)
2 +have shown that the distance between the ATP-Mn binding 
site and that of NCCD can be calculated from the interaction 
between the two spin probes to be approximately 20A. and that 
this distance increases to a value higher than 35A on 
diethyl ether extraction (180).
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CHAPTER 4 . AN INVESTIGATION OF 'THE IP;2+ ATPase OF MUTANTS 
OP S. CEREVISIAE WITH LOWERED SENSITIVITY TO OLIGOMYCIN
4.1. Introduction
Classically, elucidation of the mechanism of oxidative 
phosphorylation has been pursued by the isolation of 
"coupling factors", presumed to be intermediates in the 
energy conservation process, and reconstitution of various 
enzymic activities in depleted particles by these partially 
purified membrane fractions. The degree of confusion 
arising from the heterogeneity of some of these factors, 
and the variety of mechanisms by which reconstitution may 
operate, leads one to question the value of this approach. 
Two alternative approaches to this problem are the labell­
ing of specific proteins by inhibitors acting at known 
sites of oxidative phosphorylation (1 5 , 16), and the 
genetic manipulation of yeast to produce a modified 
coupling system (102, 181). Mutants of Saccharomyces 
cerevisiae, resistant to inhibitors of oxidative phos­
phorylation such as oligomycin, venturicidin and triethyl 
tin compounds, have been isolated in this laboratory 
(110, 112, 114). These mutants have been shown to possess 
a modified coupling system in which both ATP/Pi exchange 
and ATPase are resistant to the inhibitors (116, 182). 
Although this lowered sensitivity has been shown to exist 
in the OS-ATPase complex (116, 183), and that the site of 
the modification lies in the so called "membrane fraction", 
no protein of the mitochondrial membrane has so far been 
shown to have been altered in the mutants. It has been
■fAA
suggested that the lowered sensitivity of the mutants 
may arise from a modification of the lipid composition of 
the OS-ATPase (183), although this would seem unlikely 
in view of the cytoplasmic nature of the mutations (111, 
1 1 3)- The protein nature of the oligomycin binding site 
has not been shown in any unequivocal experiment, although 
the oligomycin and F^ binding sites appear to be trypsin 
labile (192). OSCP, once thought to be the site of 
action of oligomycin, is almost certainly not the (sole) 
binding site of the inhibitor (7^), and is not the component 
modified in the oligomycin resistant mutants. It was 
decided, therefore, to investigate the cross resistance 
of oligomycin resistant strains to DCCD, an inhibitor of 
oxidative phosphorylation which is thought to act by 
covalent interaction with a protein of the OS-ATPase 
complex (52, 78).
4.2. Methods and Materials
Strains and Growth of Yeast
The yeast strain used in this study was D22 (adp34- ),
and the mutants isolated from this parental strain as 
described by Avner (110, 184). Batch culture was carried 
out in a New Brunswick Fermentor in 10L of culture medium 
containing 0.1% peptone, 0.5% yeast extract, 100ml/10L 
Wickerhams salts (185), 0.05% Adenine sulphate, 1% ethanol 
and 5ml/10L tributyl citrate as an antifoaming agent.
Solid media for cross-resistance experiments was buffered 
at pH 7.5 with 0.1M phosphate.
>
Preparation of mitochondria and 05-ATPase
Mitochondria and submitochondrial particles were 
prepared as described by Watson jet al. (186). Mito­
chondria were further purified on a discontinuous sucrose 
gradient (20 - 70% v/v). Oligomycin sensitive ATPase 
was prepared according to Tzagoloff (40), with extraction 
of submitochondrial particles with 0.5% Triton X-100 and 
centrifugation of the solubilised ATPase on a continuous 
5 - 20% sucrose gradient containing 0.01% Triton X-100. 
Active fractions from sucrose density centrifugation runs 
were pooled and concentrated using Minicon Macrosolute 
concentrators.
Enzyme Assays and lipid estimation
ATPase activity was assayed by the method of 
Wakabayashi and Gunge (165) in a volume of 1ml at 50°C, 
pH 9.5. Reactions were initiated with 10/umoles ATP and 
terminated by the addition of 0.5ml 10% TCA. Phosphate 
was determined by a modification of the method of Fiske 
and Subbarow (164) scaled down to a total volume of 5ml. 
Protein was estimated by the biuret method of Gornall jrt 
al. (141) in the presence of 1% deoxycholate. Phospho­
lipid phosphorus was determined by the method of 
Bartlett (194).
Ergosterol was determined by the method of Wood (187). 
Cytochrome (difference) spectra were obtained on an SP1800 
spectrophotometer using sodium dithionite and potassium 
ferricyanide as reducing and oxidising agents.
Materials
Lipids were obtained from Lipid Products Ltd. DCCD 
and triethyl tin chloride were obtained from British 
Drug Houses Ltd. Oligomycin was obtained from Sigma 
Chemical Co. Ltd. and is a mixture of oligomycin A (15%) 
and oligomycin B (85%). Venturicidin was a gift from 
Dr. I.D. Fleming (Glaxo Laboratories, Stoke Poges, UK.). 
All other chemicals were analytical grade.
4.5. Results
DCCD is known to be an inhibitor of oxidative 
phosphorylation (52), and the toxicity of the inhibitor to 
the yeast Saccharomyces cerevisiae at the whole cell level 
can be shown to be due to such inhibition by Figs. 4.1 
to 4.5. Growth of the auxotronh DPP on non-fermentable 
substrate is totally inhibited by DCCD at the low concen­
tration of 5 g/ml as shov/n in Fig. 4.1. Growth of D22 
on fermentable substrate, however, is inhibited by DCCD 
only when the organism has adapted to a non-fermentable 
mode of growth as shown in Fig. 4.2. In addition the 
cytochrome spectra of yeast grown in the presence of 
DCCD show loss of cytochromes a and b, a characte.ristic 
result of growtjh in the presence of inhibitors of aerobic 
metabolism and restriction to fermentative growth (188).
The cross-resistances of a series of oligomycin 
resistant mutants of D22 isolated in this laboratory are 
given in Table 4.1. There appears to be no correlation 
between the oligomycin and DCCD resistances of the 0L1
F ir *  •  1• ZÍ
GROWTH OF D22? t'OI\'-FER M E ÍOTABLE SUBSTRATE
FIGURE 4.1.
1ml inocula from a culture of S. 
cerevisiae D2? vías transferred to 80ml sterile 
cultvire medium (184) with 1% ethanol as substrate. 
Growth was monitored by turbidity in an EEL color­
imeter (filter 607).
O-- O No DCCD ©---Q DCCD at S^p/ml.
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Fig 4.2.
Growth of D22  on fermentable substrate-effect of DCCD
FIGURE 4.2.
1ml inocula from a culture of S. 
cerevisiae D22 were transferred to 50ml sterile 
culture medium (184) with 1% glucose as substrate. 
Growth was monitored by turbidity in an EEL color­
imeter (filter 607)
O------O  No DCCD 9---© DCCD at 5>Jg/rnl.
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FIGURE A.3.
Cytochrome difference spectra were recorded 
on an SP1800 spectrophotometer. Cells were suspended in 
50% glycerol at 20mg/®l, sodium dithionite and potassium 
ferricyanide were used as reducing and oxidising agents.
A. Cells harvested at second stationary phase during growth 
on 2% glucose.
B. Cells grown as in A but in the presence of ^pg/ml DCCD
C. Blank (reduced vs reduced).
TABLE 4.1 . Cross-resi stance of oligomycin resistant
mutants of S. cerevisiae D22 to other
inhibitors of oxidative nhosohorylation
Mitochondrial Resistance to antibiotics
Strain locus in vivo (pg/mg)
DCCD oligomycin venturicidin TET
D22 - 0.05 0.6 0.1 4
D22 A21 0L1 O.O5 5 0.1 4
D22 A16 0L1 2 5 0.1 4
D22 A14 0L11 2 5 0.1 4
D22 A15 0L11 5 5 0.1 4
D22 C4 0L11 2 5 0.1 4
D22 A13 0L11 0.05 - - -
D22 B21 0L11 0.05 - —
D22 A19 0L111 2 5 2 4
D22 61 0L111 0.5 5 2 4
D22 62 0L111 2 5 2 4
D22 69 V1 2 0.5 - 20
Strains were assayed for resistance tc> inhibition of
growth using the dron-out procedure. The resistance level
is defined as the maximum concentration allowing normal 
growth of the strain. Glycerol medium was used, buffered 
at pH 7 .5 for DCCD, 6.25 for other inhibitors.
and 0L11 classes of mutants, but all of the 0L111 mutants 
so far tested display resistance to both DCCD and 
oligomycin. These mutants are also interesting in that 
they possess a lowered sensitivity to the inhibitor ventur- 
icidin. The lowered sensitivity of the 01/111 mutants is 
maintained at the mitochondrial level; the Mg ATPase 
of submitochondrial narticles derived from 0L111 mutants 
has a lowered sensitivity to the inhibitors DCCD (Fig. 4.4), 
venturicidin (Fig. 4.5), oligomycin (Fig. 4.6) and the 
aglycone of venturicidin (Fig. 4.7).
The resistance phenomenon in these mutants may be 
accounted for by a number of mechanisms
(a) Detoxification in the cytoplasm
(b) Mitochondrial detoxification
(c) Permeability barriers to the inhibitors
(d) Modification of the inhibitor binding site.
Mechanisms (a) and (c) may'be ruled out as resistance is 
maintained in "inside-out" submitochondrial particles.
In order to distinguish between mechanisms (b) and (d), 
and to select those mutants in which the inhibitor binding 
site is modified, the oligomycin sensitive ATPase was 
prepared from the parental strain and the mutants.
Surprisingly, since the use of the purified OS-ATPase 
of Tzagoloff (40) has been extensively reported in the 
literature, little seems to be known about the kinetics of 
ATP hydrolysis of this enzyme. A typical preparation of 
OS-ATPase from D22 is shown in Fig. 4.8. It has been 
shown that OS-ATPase oreparations may require lipids for 
maximal activity (64), and consequently OS-ATPase pupified
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DCCD Inhibition of Mg ATI’ ase in SMP: OL M I .
Fig 4.4
[DCC D]jjg/mg protein
FIGURE 4.4.
ATPase assays were performed by the 
method of Vakabayashi and Gunge (163). 
Submitochondrial particles were preincubated with 
DCCD at varying concentrations at 0°C for 18 hours.
□ — □ D22, I5Q =0.9
— 9 D22 A19, I50
A —- A D22 61 , I50 =
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Inhibition of ATPase by venturicirfin : 01. Ill .
FIGURE 4.5.
ATPase assays were performed by tbe 
method of V/akabayashi and Gunge (165). Submito- 
chondrial particles were nreincubated with venturi- 
cidin for 5 minutes at 30°C.
DP2, I5Q = 0.2
D22 A19 = 0.75
O---O
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Fig 4.C
jig oligomycin^nig protein
FIGURE 4.6.
ATPase assays were performed by the 
method of Wakabayashi and Gunge (165). Submito- 
chondrial particles were preincubated with 
oligomycin for 5 minutes at 50°C.
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Inhibition of ATPase by ventur ic idin arUycone
Fig 4.7
FIGURE 4.7.
ATPase assays were preformed as described 
by Wakabayashi and Gunge (163). Submitochondrial 
particles were preincubated with venturicidin aglycone 
for 5 minutes at 30°C.
o — — O D22, I 50 = 8
A— — A D22 A21, I 30 = 20
D— — □ D22 A19, ho = 20
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Fig 4.8
Preparation of OS-ATPase:Density gradient centrifugation
FIGURE 4.8.
Density gradient centrifugation of the 
triton extract of submitochondrial particles was 
performed as described by Tzagoloff (40) on a 
5 - 20% sucrose gradient.
O___o ATPase activity in the absence of exogenous
lipid.
9---® ATPase activity in the presence of Asolectin.
• 4!  * k .
from D22 was titrated with a variety of lipids to 
determine the degree and specificity of any such stimulation. 
The results (Figs. 4.9 and 4.10, Table 4.2) indicate that 
the degree of stimulation by the various lipids is very 
similar, but the concentration of each lipid required for 
half maximal stimulation of the ATPase is markedly different. 
Ergosterol does not stimulate the ATPase at all, while 
maximal stimulation is given by the unsaturated fatty acids 
and by phosphatidic acid. Lowest stimulation is found 
with saturated fatty acids. There appears to be no 
structure-function relationship between the stimulatory 
and physical properties of the lipids. The stimulatory 
effect is due to a lowering of the Km (ATP) of the enzyme 
as illustrated in Fig. 4.11. Although the lipids change 
the catalytic activity of the enzyme, they do not affect 
the inhibitor sensitivity at low concentrations, nor do 
they alter the pH deoendance of the ATPase (Table 4.3 and 
Fig. 4.12). Accordingly, all assays were performed in 
the presence of a mixture of lipids at the concentration 
giving maximal stimulation as determined by titration as 
shown in Fig. 4.13. Reported ergosterol differences in 
the OS-ATPase of mutants and parental strains (183, 189) 
prompted an assay of this lipid in the mutants under 
investigation. As can be seen in Table 4.4, there is no 
correlation between the ergosterol content of the ATPase 
and the sensitivity to inhibitors of oxidative phosphor- 
■yibet't'lon.
Titration of the OS-ATPase with DCCD shows that the 
resistance of the mutants is retained in the purified
1 1 3
F ig  4.9
Double reciprocal plot of titiations of OS-ATPase
with different fatty acids
FIGURE 4.9.
ATPase assays were performed as 
described by Vakabayashi and Gunge (163). OS-ATPase 
was preincubated with sonicated lipid at 30°C for 
5 minutes.
□---□  palmitic acid, O---O linoleic acid,
•---C oleic acid.
/
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Double reciprocal plot of titrations of OS-ATPase with
different phospholipids
FIGURE 4.10a.
ATPase assays were performed as 
described by Vakabayashi and Gunge (163)« OS-ATPase 
was preincubated with sonicated lipid at 30°C for 
5 minutes.
O__O phosnhatidylserine,
• — 9  lysophosnhatidylcholine,
A — A  nhosphatidylcholine.
Double reciprocal plot of titrations of 03-ATPase with
different phospholipids.
FIGURE 4.10b.
ATPase assays were performed as 
described by Wakabayashi and Gunge (16$). OS-ATPase 
was preincubated with sonicated lipid at $0°C for 
5 minutes.
A ---A  phosphatidic acid,
O--- O diphosphatidylglycerol,
•--- O lysophosphatidylcholine.
TABLE A.2. Activation of OS-ATPase by exogenous lipid
Lipid
phosphatidylserine 
phosohatidylcholine 
lysophosphatidylcholine 
diphosphatidylglycerol 
phosphatidic acid 
oleic acid 
palmitic acid 
linoleic acid
Ka*
pmole/mg
Vm*
^mole/min
0.61 19.2
0.83 16.6
lAK\•o 16.6
5-50 17.5
0. 31 19.0
1.48 22.7
1-35 13-2
3.92 22.7
Data calculated from figures 4.9 and 4.10.
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Fin 4.11
Lipid activation of ATPaco
FIGURE A.11.
ATPase assays were performed as described 
by U'akabayashi and Gunge (165)- OS-ATPase was 
Dreincubated with oleic acid at 30°C for 5 minute.
O--O OS-ATPase Km (ATP) = 11.76mM
0 --© OS-ATPase + oleic acid Km (ATP) = 3-6mM.
V , I I j ; *v • .
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of OS-ATPase
TABLE A.3. Effect of exogenous lipid on the inhibition
Lipid % Inhibition 
by DCCD
% Inhibition 
by oligomycin
- 66% 52%
oleic acid 62% 50%
phosphatidic acid 65% 48%
phosphatidylserine 59% 50%
lysophosphatidylcholine 59% 45%
ATPase assays were performed as described by 
Wakabayashi and Gunge (163). OS-ATPase was preincubated 
with DCCD for 18 hours at 0°C, with oligomycin for 5 
minutes at 30°C, and with lipids for 5 minutes at 30°C. 
Oligomycin concentration was 10/Lig/mg, DCCD concentration 
was 3)jg/mg and lipids were added at their half maximal 
activation concentrations (see Table 4.2).
Fig 4.12
Effect of oleic acid on pH dependence of OS-ATPase
FIGURE 4.12.
ATPase assays were performed as described 
by Vakabayashi and Gunge (165). Open circles, ATPase 
without exogenous lipid; filled circles, ATPase activated 
by oleic acid,
□ — □  Tris-maleSrreT— O — ©• Tris -acetate,
A — A Tris-chloride, O —O  Mes,V— V  Hepes.
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Fig 4.13
Activation of OS ATPase by Asclcctin
FIGURE 4.15.
ATPase assays were performed as 
described by Wakabayashi and Gunge (163). OS-ATPase 
was preincubated with asolectin at 30°C for 5 minutés.
» r
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TABLE 4.4. Errcosterol content of snbnntochondrial particles
and OS-ATPase
V
Strain Ergosterol content
Submitochondrial OS-ATPase 
particles
(nmoles/mg protein)
D22 58 100
D22 A16 ^9 -
D22 A15 19 50
D22 A21 80 150
Ergosterol was extracted and estimated as described 
by Woods (187). Submitochondrial particles and OS-ATPase 
were prepared as described in Methods.
enzyme (Fig. 4.14). This is also the case for oligo- 
mycin and venturicidin. Moreover, the degree of resistance 
remains substantially the same whether the enzyme is 
membrane bound or not. The 0L111 mutants D22, A19 and 
D2261 show a marked resistance to DCCD at the whole cell, 
mitochondrial and purified enzyme levels and were selected 
for further investigation, as these are also cross 
resistant to venturicidin. The mutant D22A21 was also 
selected for structural studies as this oligomycin 
resistant mutant is not cross resistant to DCCD or 
venturicidin.
4.4. Discussion
The investigative approach adopted in this laboratory 
is the isolation of mutants of S . cerevisiae resistant to 
inhibitors of oxidative phosphorylation and the subsequent 
selection of those mutants with an altered oligomycin 
sensitive ATPase. That this approach is applicable to 
the inhibitor DCCD is evident from the data provided by 
experiments conducted both at whole cell and subcellular 
levels. The value of such an inhibitor, with a well 
known chemistry (140), and reacting covalently with some 
specific membrane component (78), is that a subunit of 
the ATP synthetase altered in the selected mutants, may 
be specifically labelled and isolated. Moreover, as the 
step at which DCCD acts in the process of ADP phosphorylation 
is known, such a labelled component is implicated in the 
reactions at that step in the phosphorylation sequence. 
Oligomycin and DCCD have been presumed to act at the same
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Fig 4,15
inhibition of OS ATPasc by DCCD (OLili)
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FIGURE 4.15.
ATPase assays were performed as 
described by Wakabayashi and Gunge (163). OS-ATPase 
was preincubated with varying amounts of DCCD at 
0°C for 18 hours.
• ----•  D 22 A19
O— O D22
site (158, 159), in both inhibitory and stimulatory 
properties. It is unlikely that tha inhibitors share a 
common binding site, considering the dissimilarity of 
structure, although both sites could be present on the 
same subunit of the ATP synthetase. This would seem to 
be borne out by the cross resistance data, as cross 
resistance to all the mutants mapping at one locus is 
only found for 0L111 mutants. 0L111 mutants, in addition 
to their cross resistance to DCCD, possess a lowered 
sensitivity to venturicidin, an inhibitor possessing a 
structure similar to oligomycin but containing a sugar 
residue (54). The cross resistance data at the whole 
cell level is substantiated by titrations of the ATPase 
activity of purified and membrane bound ATPase, demonstrating 
that the altered resistance is due to a modification of 
the inhibitor binding site, and not to decreased permea­
bility or detoxification.
The inhibition curves for the membrane bound ATPase 
also provide some information on the binding of venturi­
cidin. The 0L111 mutant A19 is resistant to oligomycin, 
venturicidin and DCCD. The 0L1 mutant D22A21 is resistant 
to oligomycin but has no cross resistance to venturicidin 
and DCCD. The inhibitor Venturicidin X, the aglycone of 
venturicidin, acts like oligomycin rather than venturicidin 
in that the mutants D22A19 and D22A21 are both resistant 
to the aglycone, and also in the high concentrations of 
inhibitor required for maximal inhibition. This implies 
that there are two binding sites for venturicidin, one 
similar (or identical) to the oligomycin binding site and
one in which the rhamnose sugar is. involved in binding.
The Triton X-100 solubilised OS-ATPase described by 
Tzagoloff (AO) has the advantages of being an easily 
purified, homogeneous preparation, in contrast to the other 
OS-ATPase complexes described in the literature (58 - 62). 
In addition, the preparation of such a complex from a 
facultative anaerobe such as S. cerevlsiae. which may be 
genetically or phenotypically manipulated to produce 
controlled modifications of the complex, provides the 
mitochondriologist with a powerful research tool for the 
investigation of the mechanism of ATP synthesis. It is 
somewhat surprising therefore, that the properties of the 
OS-ATPase, in particular the activation by lipids and 
the effect of such stimulation on the inhibitor sensitivity 
of the enzyme, have not been described in the literature, 
although corresponding work on the beef heart ATPase has 
been reported (40, 58 - 64). In agreement with the 
findings of Swanljung (64) and Cunningham (65) on the 
beef heart OS-ATPase, all phospholipids and fatty acids 
tested are competent to stimulate ATPase activity.
However, the yeast OS-ATPase differs from the beef heart 
enzyme in that maximal activation is provided by phospha- 
tidic acid and not be lysolecithin, which is the poorest 
activator of all of the phospholipids, giving the lowest 
maximal activation.
Swanljung (63) has shown that addition of phospho­
lipid to the lipid depleted OS-ATPase from beef heart 
mitochondria lowers the Km (ATP). Cunningham (64) 
however, has shown that although exogenous phospholipid
4 0 *7Itm I
increases Vmax of CFQ.F,p the Km (ATP) is identical in
unactivated and asolectin treated preparations. The
yeast OS-ATPase is similar to that of Swanljung in that
V is increased and Km (ATP) is lovrered on addition of max
lipid. The mechanism by which the lipid activates the 
ATPase complex is suggested by the finding by Cunningham 
that diglycerides do not stimulate CF^F^ (64). Verkleij 
(65) has shown that diglycerides do not form a bilayer 
structure in aqueous solution, unlike phospholipids and 
fatty acids. It is possible therefore that the OS-ATPase 
must be incorporated into a lipid bilayer for maximal 
activity, in accordance with the chemiosmotic hypothesis 
of Mitchell(3) of which the major premise is the orient­
ation of the ATPase in the membrane. Ergosterol, one of the 
major components of the OS-ATPase, does not stimulate the 
OS-ATPase activity, nor does it readily form vesicles.
It is perhaps surprising that although phospholipids and 
fatty acids affect the kinetic properties of the OS-ATPase, 
exogenous phospholipid has no effect on either pH 
dependance or inhibitor sensitivity, especially in view of 
the data presented in Chapter 3. However, the OS-ATPase 
as prepared contains 10% endogenous lipid (40), and it may 
be that this strongly bound phospholipid plays an important 
role in the functioning of the ATPase. Moreover, the 
loss in inhibitor sensitivity found in Chapter 3 is due 
to a drastic change in the fluidity of the membrane, causing 
a change in the conformation of the OS-AiCfftSe: the 
endogenous lipid may fulfil the function of holding the 
enzyme in the conformation which is inhibitor sensitive.
CHAPTER 3
Investigation of the DCCD binding site in S. ccrevisiae
5.1. Introduction
DCCD has been shown to inhibit energy linked reactions 
in mitochondrial prenarations derived from both rat liver 
and beef heart (5?), and to bind covalently and 
specifically with a low molecular weight probed ipid at 
comparable levels to those producing inhibition. Avner 
and Peers (190) found that 1;iC DCCD only binds to yeast 
mitochondria at levels much lower than those required for 
inhibition. Broughall (152) has confirmed and extended 
these observations and has found that most of the applied 
inhibitor is only recoverable as the hydration product 
dicyclohexylurea (DCU). By analogy with the proposed 
mechanism of DCCD inhibition in red blood cell ATPase (191), 
Broughall has suggested that DCCD does bind covalently 
to yeast mitochondrial membranes, but that the resulting 
"activated carboxyl" is unstable due to the proximity of 
a membrane nucleophile, which forms a peptide bond and 
releases DCU (152). Some evidence, using the external 
nucleophile glycine ethyl ester, has been produced to 
support this hypothesis.
It has long been known that the composition of the 
mitochondrial membrane is extensively modified by 
environmental factors such as availability of oxygen or 
catabolite repression (188, 19?)« It is also possible 
to deplete the mitochondrial membrane of specific proteins 
by treatment with chaotropic agents such as urea and
detergents. It should be possible therefore to modify 
the yeast mitochondrial membrane in such a way as to 
decrease the cleavage of the DCCD-membrane adduct and 
to identify the species responsible for inhibitor binding. 
Such an approach, if combined with manipulation of the 
mitochondrial protein synthesis system with appropriate 
inhibitors such as cycloheximide and chloramphenicol 
should also give valuable information on the biogenesis 
of the ATPase complex.
5.2. Methods and Materials
Yeast growth and preparation of mitochondria
Aerobic and anaerobic growth of S. cerevisiae strain 
D22 (ad2 ,â ) and the preparation of mitochondrial membranes 
were as previously described (186). Mitochondria and 
Dromitochondria were further purified by sucrose density 
centrifugation. ^e tP (^a^r) an  ^"^ETP NH^OH)
were prepared as described by Tzagoloff (70).
Binding of DCCD
Submitochondrial particles (2mg) were incubated in 
5ml 250mM Sucrose, 10mM Tris-acetate pH 7 .5 at 0°C with 
varying amounts of DCCD. After 18 hours incubation, the 
suspension was centrifuged at 100,000g for 30 minutes and 
the pellet counted by liquid scintillation after dissolution 
in 1ml 2% (w/v) Triton X-100.
Assay procedures
ATPase activity was assayed by the method of 
Wakabayashi and Gunge (163), nhosphate was estimated by
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the method of Fiske and SubbaRow (164), modified as 
described in 4.2. Protein was estimated by the biuret 
method of Gornall ht al. (141), in the presence of 1%  
deoxycholate.
DCCD/DCU mixtures were separated on Alumina plates 
(Merck, aluminium sheets) in Benzene/Ethyl acetate (9=1 
v/v). Chloroform/Met hand (2:1 v/v) extraction of
mitochondrial membranes was carried out as described by 
Cattell _et al. (78). Triton extraction and precipitation 
with antisera to OS-ATPase was nerformed as described by 
Tzagoloff (40). Antisera to OS-ATPase was obtained from 
rabbits. Rabbits were immunised with 8mg OS-ATPase 
according to Schatz jwt aJL. (35)-
Materials
1/+C DCCD was a kind gift from Prof. R.B. Beechey 
(Shell Research Ltd., Sittingbourne). DCCD was purchased 
from BDH. leucine was purchased from the Radiochemical
Centre (Amersham). 4-Amino-2,2,6,6-tetramethylpiperid-1- 
yloxy was purchased from R. Emanuel Ltd. All other 
reagents were analytical grade.
5.3. Results
Binding of ^ C  DCCD to aerobic mitochondria
Incubation of ^ C  DCCD with mitochondria, submito- 
chondrial particles and isolated OS-ATPase from S^. 
cerevisiae grown aerobically on ethanol gave negligible 
binding of the inhibitor as shown in Table 5.1.
1 ¿4-TABLE 5.1 . Binding of C DCCD to mitochondrial membranes
from aerobically grown .yeast
nmoles/mg
DCCD
% bound
Mitochondria 1.0 3.1
SMP 1.0 3.3
OS-ATPase 5.0 5-0
DCCD was incubated with the membrane ^reparations 
at the concentrations shown at 0°C for 18 hours. The 
mitochondria and submitochondrial narticles were 
centrifuged down, the OS-ATPase was nrecipitated with an 
equal volume of 10% TCA. Radioactivity was counted by 
liquid scintillation in Triton/toluene/butyl PBD.
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Loss of DCCD sensitivity
As can be seen in Fig. 5-1 •» the inhibitory potency 
of DCCD is diminished by preincubation of the submito- 
chondrial oarticles with a nucleophilic spin probe 
(4-amino2,2,6,6-tetramethylpiperid-1-yloxy). The degree 
of inhibition is dependant on the concentration of 
nucleophile at any given concentration of DCCD (Fig. 5-2.). 
This reduction in potency is not due to direct reaction 
of nucleophile with DCCD as shown by TLC of DCCD, spin 
probe, and a combination of the two on alumina plates 
in Benzene/Ethyl Acetate (9=1 v/v). Although this 
displacement of DCCD from the membrane was expected to be 
accompanied by a concomitant binding of nitroxide label, 
no E.S.R. signal could be detected. Reduction of the 
probe cannot be ruled out, even though incorporation was 
carried out in the presence of ferricyanide. Altern­
atively, the nrobe may be almost totally immobilised 
(as in the case of NCCD (179)), and the signal too broad­
ened to detect at the low levels of probe used.
Binding of DCCD to YETp (NaBr, NH^OH)
Depletion of F^  from yeast submitochondrial particles 
increases the degree of binding of C DCCD from 3% to 
38%, and depletion of both F^ by NaBr treatment, and OSCP 
by NH^OH treatment increases the degree of binding to 
almost 50% as shown in Table 5-2. As can be seen in 
Fig. 5.3., this increased binding of DCCD to Y£Tp (NaBr, 
NHZt0H) is due in part to the existence of a high affinity 
site which is not detectable in normal aerobic mitochondrial
Fig 5.i
Inhibition of ATPasc in YETP by DCCI)
FIGURE 5.1.
ATPase assays were performed as described 
by Vakabayashi and Gunge (163). DCCD and 
A-amino-?,?,6,6 tetramethyloinerid-1-yloxy were 
preincubated with yeast submitochondrial particles for 
18 hours at 0°C.
O--- O  No spin probe
O- — --O Inmole spin prohe/mg protein.
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Fig 5.2
Dependance of DCCD inhibition on [nucleophile]
FIGURE 5.2.
ATPase assays were performed as 
described by Vakabayashi and Gunpe (165). DCCD 
and 4-amino tetramethylniperid-1 -yloxy
v/ere preincubated with yeast submitochondrial 
particles for 18 hours at 0°C. DCCD concentration 
was 2nmoles/mg protein.
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TABLE 5.2. Binding of DCCD to YETp (NaBr) and YETp
(NaBr, NH^OH)
cpm ^ C  %  ^^ C bound
y etp 60,000 5
y e tp (NaBr^ 855,000 38
YETP (NaBr’ NH40H) 917,000 49
20mg mitochondrial particles were incubated with 
2 x 106 com 14C DCCD (1nmole/mg), at 0°C for 18 hours. 
Particles were washed with 5 ml sucrose-tris. Radio­
activity was determined by liquid scintillation in 
Triton/toluene/butyl PBD.
Fig ü.3
BINDING OF DCCD TO YETP(PJaBr,NH4OH): OLr AND OLS .
FIGURE 5-3.
YETp (NaBr, NH^OH) were prenared as 
described by Tzagoloff (70). Depleted particles 
(2mg) viere incubated with varying amounts of DCCD 
at 0°C for 18 hours in 5ml 250mM Sucrose, 10mM Tris- 
acetate nH 7.5. The susnension was centrifuged at 
100,000g. for 50 minutes and the oellet counted by 
liquid scintillation after solubilisation in 2%
triton X-100.
A --^  D22, O--Cl D22 A19, O--O D22 A21.
membranes. No difference could be detected in the low 
affinity site between D22 parental and the DCCD resistant 
mutant D22 A19, and the specific activity of the DCCD 
available is not high enough to resolve the high affinity 
site and differentiate between mutant and parental strain, 
n aBinding of C DCCD to promitochondria 
14Binding of C DCCD to promitochondria isolated from 
S. cerevisiae grown under strictly anaerobic conditions is 
shown in Fig. 5-A. As in the case of YETp (NaBr, NH/+OH), 
the increased binding is due to a high affinity site 
present in anaerobic mitochondria and not in aerobic 
mitochondria. These are anproximately 1.5nmoles of high
g
affinity site/mg mitochondrial nrotein, = 1 . 7  x 10 M. 
Nature of the binding site
Incubation of 1^C DCCD with YETp (NaBr, NH^OH) leads 
to binding of some 50% of the applied inhibitor.
Examination of the unbound counts by TLC shows that approx­
imately half of the unbound inhibitor is present in the 
supernatant as DCU, and half as protein which does not 
migrate: no counts are found in the position corresponding 
to DCCD (Fig. 5.5.). Chloroform/methanol extraction of
the washed DCCD treated YETp NaBr, NH^OH) removes 95% 
of the bound counts, and TLC of this extract is shown in 
Fig. 5.6. The inhibitor is predominantly present as a 
species which does not migrate in Benzene/Ethyl acetate 
(9:1 v/v) with only small amounts of DCCD and DCU.
Lipids migrate easily in this solvent system, while 
proteins do not.
BINDING OF DCCD TO YETP FROM AEROBIC AND ANAEROBIC
YEAST
1 2 3 4 5
DCCD Bound (nmole/mg protein)
FIGURE 5-A.
Promitochondria and mitochondria were 
prepared as in Methods. Depleted particles (2mg) 
were incubated with varying amounts of DCCD at O C 
for 18 hours in 5ml 250mM Sucrose, 10mM Tris-acetate 
pH 7.5. The suspension was centrifuged at 100,0CO£ 
for 30 minutes and the nellet counted by liquid 
scintillation after solubilisation in 2% triton X-100. 
promitochondria 
mitochondrial band (aerobic) 
mitochondrial band (anaerobic).
O--O
A — A
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Fig 0.5
TLC OF SUPERNATANT : DCCO BINDING TO YETP(FJaBrNH40!l)
CPM
x10-3
Distance (cm)
FIGURE 5-5.
DCCD was incubated with depleted 
yeast submitochondrial particles at 2nraole/mp;, for 
18 hours at 0°C. The suspension was centrifuged 
at 100,00C£ for 30 minutes and the supernatant 
extracted with chloroform-methanol (2:1 v/v). The 
extract was reduced in volume on a rotary evaporator 
and run on an aluminium oxide TLC plate in benzene/ 
ethyl acetate (9:1 v/v).
4,in
Fiy G.G
T.L.C : CHLOROFORM METHANOL EXTRACT Of YETP ( NsCr. NH^OH)
FIGURE 5-6.
DCCD was incubated with Y ^ p  (NaBr, 
NH/+OH) for 18 hours at 0°C. The particles were 
centrifuged down at 100,000^ and extracted for 18 hours 
with 20 volumes chloroform/methanol (2:1 v/v). The 
extract was reduced in volume on a rotary evaporator 
and run on an aluminium oxide TLC plate in benzene/ 
ethyl acetate (9:1 v/v).
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Triton X-100 extraction of both YgTp (NaBr, NH^OH)
and anaerobic mitochondrial membranes solubilises the
membrane bound inhibitor, and this solubilised inhibitor
may be precipitated by antisera to the OS-ATPase complex
as shown in Table 5-3., indicating the presence of the
binding site in the OS-ATPase.
leucine was incorporated into mitochondrial
membrane proteins as described by Tzagoloff (70). Triton
X-100 extraction of these membranes removed some 10 - 15%
of the total radioactivity and this was almost totally
precipitable by antisera to OS-ATPase. SDS-polyacrylamide
gel electrophoresis of the antisera precipitate from
triton extracts of leucine labelled mitochondrial
membranes and from ^ C  DCCD treated X ^ p  (NaBr, NH^OH) are
shown in Figs. 5-7» and 5-8. The only band found on
the latter gel runs at a position corresponding to a
protein of 45,000 molecular weight, corresponding to a consistently
3observed peak in the antisera precipitate gel from 
labelled mitochondria. Tzagoloff has identified this 
band as an incompletely solubilised polymeric form of the 
proteolipid subunit 9 (76). Conversion of this polymeric 
form to the monomer may be accomplished by treatment with 
alkali, which is not possible in this case, due to the 
lability of the DCCD-protein bond.
Biogenesis of the DCCD binding site
Inhibition of ATPase activity in mitochondria prepared 
from derepressing cells is almost invariant as shown in 
Fig. 5.9. S. cerevisiae D22 was grown in 5.4% glucose
1 «
TABLE 5.3. Precipitation or triton extracts with antisera
to OS-ATPase
14
Promitochondria 
YETp (NaBr, NH^OH)
Triton
extract
11,860 
38,900
C DCCD (cpm)
Antisera
precipitate
4,350
26,821
%
precipitated
37
69
DCCD was incubated at 2nmole/mE with oromitochond- 
rial particles or Y ^ p  (NaBr, NH^OH) for 18 hours at 0°C. 
Washed particles were extracted with 0.5% Triton X-100 
and antisera precipitates were preoared as described by 
Tzagoloff (40). Precipitates were dissolved in 2% triton 
X-100 and counted in triton/toluene/butyl PBD.
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TABLE 5.3. Precipitation of triton extracts with antisera
to OS-ATPase
14C DCCD (cpm)
Triton Antisera %
extract precipitate precipitated
Promitochondria 11 ,860 4,350 37
YE,rp (NaBr, NH^OH) 38,900 26,821 69
DCCD was incubated at Pmaole/rng with oromitochond- 
rial particles or YETp (NaBr, NH^OH) for 18 hours at 0°C. 
Washed particles were extracted with 0.5% Triton X-100 
and antisera precipitates were prepared as described by 
Tzagoloff (40). Precipitates were dissolved in 2% triton 
X-100 and counted in triton/toluene/butyl PBD.
Fig 5.7
Antisera précipitais : Triton extract
FIGURE 5.7.
DPP S. cerevisi ae were grov.’n for 1P hours in 
a 5.4% glucose medium. The cells were harvested and 
transferred to a medium containing Pmg/ml chloramnhenicol 
and 0.8% glucose. After aeration for 6 hours, the 
harvested cells were grown in a medium containing 0.8% 
glucose, 10“ ^M cycloheximide and 1 .25/iCi ' ’ll leucine/ml. 
for 20 hours. The cells were harvested and washed. 
Mitochondria and submitochondrial particles were prepared 
as described in Methods. Triton extraction and precipit­
ation with OG-ATPase antisera were performed as described 
by Tzagoloff (70). Polyacrylamide gel electrophoresis 
was as described by Weber and Osbourne (143).
Slice number
FIGURE 5.8.
SDS-rel electrophoresis of the DCCD binding 
site in YETp (NaBr, NH^OH)
YEtp (NaBr, NH/+OH) were prepared as described by 
Tzagoloff (70) and incubated at 0°C for 18 hours with
DCCD. Triton extraction and antisera precipitation 
were as described by Tzapoloff ('40, 70). Polyacrylamide 
pel electrophoresis was as described by Weber and Osbourne 
(143).
1 4 9
Fig 5.9
Rcrcprcssion of D22.
[DCCD] pg/mg
FIGURE 5.9.
Derepression of yeast in the presence of 
chloramphenicol and cycloheximide was carried out by the 
method outlined in the text. DCCD was preincubated 
with submitochondrial particles for 18 hours at 0 C.
ATPase assays were performed as described by Wakabayashi 
and Gunge (165).'
□ □  0 hours, O— O 5 hours, A — A  6 hours.
I
for twelve hours, and the glucose repressed cells were 
harvested and transferred to fresh culture medium containing 
chloramphenicol (2mg/ml) and 0.8% glucose and aerated for 
six hours. Under these conditions synthesis of essential 
(glucose repressed) cytoplasmically synthesised proteins 
is initiated, but synthesis of protein on mitoribosomes 
is inhibited (91). The yeast was harvested and a 
suitable aliquot broken for preparation of mitochondria, 
the remainder being inoculated into 0.8% glucose medium 
containing cycloheximide (10~^M). Aliquots of the 
culture v/ere harvested at 3, 6 and 18 hours. I^q values 
for DCCD inhibition of membrane bound ATPase change only 
by a small amount but the amount of inhibitor sensitive 
ATPase increases. At 0 hours the total inhibition is 
80%, at 6 hours 100%. At the same time, the proportion 
of unincorporated F in the cytoplasm decreases at a rate 
comparable to a concurrent increase in specific activity 
of DCCD sensitive membrane bound ATPase, as shown in 
Table 5.4.
Qualitatively the same results are obtained on 
derepression of the oligomycin mutants D22 A19 (Pig. 5-10.) 
and D22 A21 (Fig. 5.11.). In both cases, the I^Q values 
for DCCD inhibition are approximately the same during 
derepression, slightly more inhibitor being required at 
0 hours. The degree of inhibition is consistently lower 
at 0 hours, although this is more pronounced in the case 
of D22 A19. Resistance and sensitivity to DCCD is 
maintained throughout. Derepression of D22 in the absence 
of chloramphenicol or cycloheximide gives a similar result
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TABLE 5• • Biogenesis of OS-ATPase
Aurovertin sensitive Al’Pase
, . -1 -1^mole min mg
Time after 
derepressi on 
(hours)
0
1
3
submitochondrial 
particles
1.3
1.8
2.85
post-ribosomal
supernatant
0.08
0.06
0.032
S. cerevisiae D22 was grown in 5-^% glucose medium 
for’12 hours. The cells were harvested and transferred 
to 0.8% glucose medium containing 2mg/ral chloramphenicol. 
After 6 hours growth, the cells were harvested, washed and 
transferred to 0.8% glucose medium containing 10”^M 
cycloheximide. Aliquots were harvested for preparation 
of submitochondrial oarticles at 0, 1, 3hours. Post- 
ribosomal supernatants were centrifuged at 160,000^ for 2 
hours. ATPase was measured by the method of Vakabayashi 
and Gunge (163).
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Fig 5.10
Derepression of D22 A19
FIGURE 5.10.
Derepression of yeast in the presence of 
chloramphenicol-xand cycloheximide was carried out by 
the method outlined in the text. DCCD was 
preincubated with submitochondrial particles for 18 
hours at 0°C. ATPase assays were performed as 
described by Wakabayashi and Gunge (163).
□ — □ i  hours, A — A  3 hours, O— O 6 hours.
SENSITIVITY OF M g 2+ATPase TO DCCD (D22A21)
f i g u r e 5.11.
Derepression of yeast in the presence of 
chloramphenicol and cyeloheximide was carried out by 
the method outlined in the text. DCCD was 
preincubated with submitochondrial particles for 18 
hours at 0°C. ATPase assays were performed as 
described "by Wakabayashi and Gunge (163).
O— O 0 hours, □— □ 1 hour, A — A 3 hours.
fro¡«/u
(Fig. 5.12.), although the lowered total inhabitable 
ATPase for repressed mitochondrial membrane is not as 
marked.
1  ¿ 1Binding of C DCCD is markedly affected by the 
derepression of glucose grown yeast. In a similar derep­
ression experiment illustrated in Fig. 5.1J., submito- 
chondrial particles from yeast grown on glucose
display a higher degree of binding than submitochondrial 
particles from glucose grown cells derepressing in low 
(0.8%) glucose. This decrease in binding occurs during 
the first half hour of derepression. Inclusion of the 
cytoplasmic protein synthesis inhibitor cycloheximide 
abolishes the decrease in binding on derepression in 
0.8% glucose (Fig. 5.14.) and some increase in the degree 
of binding is found over the first six hours of 
derepression.
5.4. Discussion
DCCD is an effective inhibitor of mitochondrial
ATPase in yeast, as found by Roberton ejt _al. in beef heart
(139). The inhibition of beef heart mitochondrial ATPase
14may be correlated with a covalent binding of C DCCD to 
a proteolipid component of the mitochondrial membrane (78), 
which may be a subunit of mitochondrial ATPase (77). No 
such covalent binding has been demonstrated in yeast 
mitochondria (152, 190), and Broughall (152) has suggested 
that the covalently bound DCCD is removed by a membrane 
nucleophile. This would tend to be supported by the 
decrease in sensitivity found on addition of the external
Dereprcssicn of 022
[pCCDjyjg/mg protein
FIGURE 5.12.
Derepression of D22 in the absence of 
protein synthesis inhibitors was carried out as described 
in the text. DCCD was incubated with submitochondrial 
particles for 18 hours at 0°C. ATPase assays were 
performed as described by Wakabayashi and Gunge (165).
q  q  0 hours, □— □  5 hours,
O— O 6 hours, A — A  12 hours.
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Fig 5.13
dccd binding DuniriG derephession
FIGURE 5.-13.
S. cerevisiae D22 was grown in 5.4% 
glucose for 12 hours, harvested and inoculated into 
0.8% glucose medium. Aliquots were harvested at 
0, 1, 3, 18 hours. Suhmitochondrial particles
were prepared as described by Watson et al. (186). 
Binding of ^*C DCCD was performed as described in 
Methods.
O— o 0 hours, V — V  i  hour, £r~A 1 hour,
□— a  3 hours, O— O 18 hours.
DCCD BINDING DURING DEREPRESSIOiJ IN CYCLQIIEXIIUIUE
FIGURE 5.14.
S. cerevisiae D22 was grown in 5.4% gluco 
for 12 hours, harvested and inoculated into 0.8% glucose 
medium containing 10_5M cycloheximide. Aliquots were 
harvested at 0, -J, 1, 5* 18 hours. Submitochondrial 
particles were prepared as described by Watson e_t a_l. 
(186). Binding of DCGD was performed as described
in Methods.
©— ©  0 hour, V — V  i  hour, A — A  1 hour,
□— □  5 hours, O— O 18 hours.
nucleophile 4-amino-2,2,6,6-tetramethylpiperid-1 -.yloxy.
A proposed mechanism for the decrease in sensitivity is 
shown in Fig. 5.15. In the case of DCCD inhibition, 
the DCCD adduct is attacked by a neighbouring nucleophile 
(here shown as an amino group) to remove DCU and form an 
intrapeptide bond. Addition of external nucleophile 
causes release of DCU, but no intrapeptide bond is formed. 
Strain induced by the intrapeptide bond is greater than in 
the addition product found with external nucleophile.
The situation is analogous to that found in red blood cell 
ATPase by Godin and Schrier (191).
A i±Binding of C DCCD to mitochondrial membranes is 
enhanced by extraction with sodium bromide which depletes 
the membrane of F^  (70) and is further enhanced by 
subsequent extraction of OSCP by ammonia (70). Similar 
results have been obtained by Azzi (195) using the nitroxide 
analogue NCCD in urea and ammonia extracted heart mito­
chondrial particles. Azzi has found that only particles 
which are depleted of both F1 and OSCP have altered binding 
characteristics and on the basis of ascorbate reduction 
of the covalently bound probe, ascribes the altered binding 
to increased accessibility of the binding site to the 
aqueous environment (195). This may be the reason for the 
altered binding in depleted yeast membranes, but these are 
fundamental diffei’ences between the situation found in 
beef heart and yeast mitochondria. Increased binding is 
found in submitochondrial particles depleted of F^  only 
in yeast, and preliminary results with NCCD in yeast 
mitochondria (196, 19 7) suggest that the lipid environment
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P R O P O S E D  M E C H A N I S M  FOR RELIEF OF D C C D
INHIBITION OF Mg-ATPasc
of the yeast NCCD binding site is more involved in binding 
than that in beef heart.
It is perhaps not surprising that promitochondria 
from anaerobically grown yeast possess an enhanced C 
DCCD binding, considering that these membranes are 
naturally depleted of many mitochondrial enzymes by dediff­
erentiation (188). Care must be taken however in inter­
preting this data as promitochondria have only a lowered 
ATPase content (198, 199), possess functional phosphor­
ylation (200) and a modified lipid content (201). It is 
possible that in salt extracted particles, promitochondria, 
or particles from glucose repressed cells that F^ and OSCP 
are reduced in quantity and thus allow greater accessibility 
of DCCD to the binding site. Alternatively the lipid 
composition may be modified such that DCCD may bind to a 
protein component with a more favourable conformation.
The latter suggestion may be connected with availability 
of membrane nucleophile (192). The binding data suggests 
that DCCD binding in F^ depleted SMP and promitochondrial 
particles are due to a similar change in the binding 
site as binding parameters are the same in both cases 
(Fig. 9.16.).
The identity of this binding site with subunit 9 of 
the OS-ATPase is shown by (a) its extractibility into 
chloroform-methanol, indicating the proteolipid nature of 
the binding site: TLC of extracted binding site shows 
absence of either free DCU or DCCD. (b) the presence of 
the binding site in the OS-ATPase complex as shown by 
precipitation with antisera to OS-ATPase. (c) Co-migration
Firs 5.16
DCCD BINDING TO YEAST SUBMITOCHONDRIAL PARTICLES
FIGURE 5.16.
Collected data from Figures 5.3», 5.A.
YETP <NaBr» NV>H) 
rromitochondrial particles
mitochondrial particles.
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with subunit 9 in SDS-polyacrylamide gels. This agrees 
with the findings of Cattell <3t al. (78) and Stekhoven 
(77) that the binding site of DCCD in beef heart mito­
chondria is a proteolipid subunit of OS-ATPase.
Subunit 9 of the OS-ATPase is known to be synthesised 
on mitoribosomes (76). It is possible therefore to 
investigate the biogenesis of binding site by appropriate 
manipulation of the cytoplasmic and mitochondrial protein 
synthesising systems. The results of such manipulation 
indicate that (a) there is an increase in membrane bound 
ATPase over the first six hours of derepression, and a 
concurrent decrease in the free F^ content of the cytoplasm. 
The membrane proteolipids have been suggested to interact 
with OSCP and F^ in the binding of these proteins to the 
membrane (5 1). (b) over the first hour of derepression,
the degree of maximal inhibition may rise from 80 to 100%.
If proteolipid is necessary for binding of F^ ATPase, and 
also confers oligomycin and DCCD sensitivity (51)» it 
may be that although an ATPase complex is formed, the 
complex is not functional until the correct conformation, 
dictated by the }ipid environment, is obtained. The 
rapid change in the maximal inhibition (0.5 to 1 hour) does 
not correlate with synthesis of ATPase protein which takes 
place over the first 6 hours of derepression (199).
(c) The I^0 values for DCCD inhibition are not 
greatly different. Under the experimental conditions used, 
this can be taken to mean that there is little DCCD 
binding site which is not attached to OSCP and F^, the 
inclusion of chloramphenicol building up an excess of these
proteins. Although more DCCD binding site is synthesised 
in the presence of cycloheximide, this is always bound by 
the excess of OSCP and F^, and the other mitochondrial 
proteins increase at a similar rate, giving no great change 
in the I^q values for ATPase. (d) ^/+G DCCD binding
during derepression decreases over the first half-hour, 
correlating well with the proposed conformational change 
in (b). That this conformational change is produced in 
some way by a product of the cytoplasmic protein synthesising 
system is shown by an increase rather than a decrease in
■'I ¿1 .C DCCD binding found when derepression takes place m  
the presence of cycloheximide. The cytoplasmic pool of 
F^ is not present in cells grown in cycloheximide (91).
It is possible that F^ and OSCP binding promotes a 
conformational change in the ATPase complex such that 
DCCDis not bound covalently. Such a system would also be 
sensitive-to changes in the membrane environment, 
explaining the increased binding in oromitochondria and 
particles from glucose renressed yeast. That the DCCD 
sensitivity of ATPase is sensitive to its lipid environment 
has been shown by solvent extraction in Chapter 5. A 
lipid involvement in the binding of NCCD to promitochondria 
has been shown in parallel experiments to those reported
here (196, 197).
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CHAPTER G
Isolation and characterisation of subunit 9 of the OS-ATPase 
from Î3. cerevisiae D22
6.1. Introduction
The oligomycin sensitive ATPase consists of (a) the 
oligoreycin insensitive ATPase (F^ ) (b) OSCP, a basic
coupling factor (c) a membrane factor which confers inhibitor 
sensitivity on F^ ATPase. The membrane factor comprises 
four protein subunits of the ATPase complex which are 
mitochondrially synthesised (75), and one of these, subunit 
9 is probably the site of action of DCCD. The purification 
and characterisation of the membrane factors has been 
hampered by their highly hydrophobic and insoluble nature. 
Several studies have been reported in which subunits of the 
ATPase complex have been extracted and partially purified 
(78, , 76) from beef heart, rat liver and yeast, using
mixtures of organic solvents. Sierra and Tzagoloff
(76) have extensively purified the yeast protein and 
found that it has a uolarity of 0.25 according to the 
formulation of Canaldi and Vanderkooi (202), the most 
hydrophobic protein isolated thus far. The extreme 
insolubility of this proteolinid has made characterisation 
of the subunit very difficult and has neccessitated the 
development of novel techniques.
6.2. Methods and Materials 
Purification of subunit 0
Mitochondrial particles were prepared from aerobically
M Z-iIN -/*
grown yeast as previously described (186). Submitochond- 
rial particles were washed with 10 volumes of methanol and 
the pellet extracted with 20 volumes of Chloroform/Methanol 
(2/1 v/v) for 18 hours according to Cattell et al_. (78).
The Chloroform methanol extract was freed of membranes by 
filtration through a glass sinter. The chloroform-methanol 
extract was washed with 1/5 volume of distilled water and 
the organic (lower) phase reduced to 1/5 volume on a 
rotary evaporator. The washed extract was precipitated 
with cold (-20°C) diethyl ether (5 vol.) and washed twice with 
a further 5 volumes of diethyl ether. The precipitate 
was dissolved in Chloroform/Methanol (2:1 v/v) and 
separated on Silica gel PLC plates (Merck) in Chloroform/ 
MethanolA'ater (65:25:4) containing 20mM HC1. Band 2 
was scraDed from the PLC olate, extracted three times 
with Chloroform/Methanol (2:1 v/v) containing 20mM HC1.
The pooled, concentrated extracts were applied to a 
second Silica gel plate and developed in Chloroform/Methanol 
/17% NH^ (2:2:1 v/v). Band 4 was eluted into acidic 
chloroform methanol and precipitated with 5 vols. cold 
diethyl ether.
Tryptic digestion of proteolipid
Subunit 9 was covalently coupled to glass beads by a 
modification of the method of Mason and Veetall (203), 
p-nitrobenzylsulphonyl chloride replacing p-nitrobenzoyl 
chloride. Tryptic digestion of the bound proteolipid 
was performed as described by Eennett (204). Peptides 
were labelled with dansyl chloride (205), nnd separated 
on polyamide thin layers by a modification of the method
of Woods and Wang (206). Solvent in the first dimension 
was 1.5% formic acid, in the second dimension, n-heptane/ 
n-butanol/glacial acetic acid (3:3:1).
Partial Acid Hydrolysis
Cleavage of the purified nroteolipid at aspartic acid 
vras performed as described by Tsung (207) in O.OJN 
hydrochloric acid. Peptides were labelled with dansyl 
chloride (205) and separated by the method of Woods and 
Wang (206).
N-terminal determination
Identification of the N-terminal amino acid was 
performed as described by Gray (208). Dansylated proteo- 
lipid was hydrolysed in 6.?N hydrochloric acid at 100°C 
and the N-terminal amino acid identified by the method of 
Hartley (209).
Polyacrylamide gel electrophoresis
Electrophoresis of the proteolipid in 3DS containing 
solvent was as described by Weber and Osbourne (143).
Gels were stained in 1% amido black and destained in 7% 
acetic acid. Gels containing radioactivity were sliced 
using a stacked razor blade assembly (210), and 1mm slices 
dissolved in 6% hydrogen neroxide prior to scintillation 
counting in Triton X-100/toluene/butyl PED (144).
6.3. Results
Purification of nroteolioid
The purification of a protein which has no enzymic
IS
properties and no coupling factor activity presents certain
problems in the determination of purification, yield and
purity. The presence of the proteolipid has been
*monitored by the incorporation of H leucine into the 
products of mitochondrial protein synthesis. Subunit 9
is known to be synthesised on mitoribosomes (76). A
*typical preparation from H labelled submitochondrial 
particles is shown in Table 6.1. It can be seen that 
large amounts of other material are still present as 
contaminants of the proteolipid spot in the first TLC run 
(Figs. 6.1., 6.2.). The extraction method removes more 
protein from SMP than that of Sierra and Tzagoloff (76) 
and the final yield is about eight times higher. Although 
washing steps are included in the preparative method, the 
presence of contaminants even after the first chromato­
graphic separation suggests that the extraction procedure 
is not as specific for subunit 9 as .that of Sierra and 
Tzagoloff (76). Attempts at separation of the yeast 
proteolipid on Senhadex LH20 columns developed in varying 
concentrations of chloroform-methanol gave a number of 
protein peaks, probably due to the aggregation of protein 
on the column, or differences in solubility of more or 
less denatured protein. It was found that the precipitated 
protein was very difficult to redissolve and that the 
further along the preparative procedure, the greater the 
insolubility. This behaviour is found in both rat liver 
and beef heart mitochondrial proteolipids, and is 
responsible for major losses of material.
The homogeneity of the proteolipid may be assessed
TABLE 6.1. Purification of subunit 9
Total protein cpm
(mg) (x 10"5) Stage
250 340 SMP
10.1 56.2 CHCl,/MeOH extract 3
7.6 52.1 Washed extract
5-5
O•CO«3- Ether precipitate
3.0 27.2 TLC spot 1
2.1 23-6 TLC spot 2
Purification of subunit 9 proteolipid was carried 
out as described in Methods. TLC spot 1 is band 2 from 
the first TLC run, TLC spot 2 is band 4 from the second
TLC run
TLC OF Y EA ST  3li SUBUNIT 9
FIGURE 6.1.
leucine was incorporated into yeast 
submitochondrial particles in the presence of cyclo- 
heximide as described by Tzagoloff (70)* Subunit 9 
was prepared as outlined in Methods. Crude ether 
was run on a preparative layer (5rcro) Silica gel plate
in Chloroform/Methanol/Water/6N HC1 (150:50:7.2: 0. / 2).
Spots were visualised with iodine vapour.
15
T L C  O F  Y E A S T  3 H - S U B U N I T  9
FIGURE 6.2.
leucine was incorporated into yeast sub- 
mitochondrial particles in the presence of cycloheximide 
as described by Tzagoloff (70). Subunit 9 was prepared 
as outlined in Methods. Crude ether precipitate was 
run on a preparative layer (5mm) Silica gel plate in 
Chloroform/Methanol/17% NHj (2:2:1 v/v). Spots were 
visualised with iodine vapour.
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Fig 6.3
CHROMATOGRAPHY OF CRUDE PROTEOLIPIÜ OTJ SEPHADEX LH 20
FIGURE 6.3.
Subunit 9 was prepared as outlined in 
Methods, and layered on a 20 x 1cm column of Sephadex 
LH20 in Chloroform. Protein was eluted by sequential 
addition of 50ml of Ciiloroform/Methanol 15:1 (v/v), 
10:1 (v/v), 8?1 (v/v), 4:1 (v/v), and 2:1 (v/v).
■by polyaci'ylamide gel electrophoresis as illustrated in 
14Fig. 6.4. C-DCCD labelled proteolipid migrates as one
peak on SDS containing gels and one protein staining band 
is found to coincide with this peak. Although no protein 
contaminants are present, there would appear to be some 
other strongly bound component in the purified proteolipid. 
N-terminal analysis by dansylation and hydrolysis gives 
two labelled spots on polyamide plates as shown in Fig.
6.5. One of these corresponds to dansyl-methionine, 
the other does not correspond to any dansyl derivative 
of the twenty commonest amino acids. Uncommon amino 
acids are not present in subunit 9 (76).
Characterisation of subunit 9
Attempts to digest subunit 9 with trypsin and a range 
of other proteolytic enzymes failed due to the insolubility 
of the proteolipid in non-denaturing solvents. Subunit 9 
bound to a glass support could be digested with trypsin, 
but this technique required large amounts of proteolipid.
A tryptic digest (fingerprint) of subunit 9 from the 
parental strain D22 is shown in Fig. 6.5. The theoretical 
number of spots from a normal tryptic digestion is 4: in 
this case the proteolipid is anchored to the glass support 
by at least one -NH^ side chain, and consequently the 
maximum theoretical number of tryptic peptides is 7*
Few peptides are found in the digest in detectable quantities 
and it is possible that minor components are present at 
very low levels.
No differences were found between DCCD mutant
S D S -G E L  ELECTRO PH O RESIS  OF SU BU N IT  9
SLICE N U M B E R
FIGURE 6.4.
Subunit 9 was arpnarcd as outlined in 
Methods. DCCD was bound to subunit 9 inC h l o r o f o r m /Methanol 2:1 (v/v) and precipitated with 
cold dieth.vl ether. The precipitate was dissolved 
in 3% SB3, 5% mercaptoethanol, phosphate buffer 
100;nM pH 8.9. Electrophoresis was performed as 
described by Weber and Osbourne (143).
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Fig 6.5
N-TERMIfJAL m\UQ ACID DQEP.I-.II'JATID’J : SUBL'WIT 9
FIGURE 6.5.
Subunit 9 from S. cerevisiae D22 
was purified as described in Methods. Identifi­
cation of the N-terminal amino acid was performed 
as described by Gray (208). Dansylated N-terminal 
was cochromatographed v/ith dansyl methionine by 
the method of Hartley (209). Solvent 1st 
dimension 1.5% formic acid. Solvent 2nd 
dimension Benzeme/acetic acid (9:1 v/v).
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n HEPTANE/n BUTANOL/ACETIC ACID 
(3:3:1)
FIGURE 6.6.
Subunit 9 from S. cerevisiae was 
prepared as described in the text. Subunit 9 was 
covalently coupled to glass beads by the method of 
Mason and Weetall (203). Tryptic digestion was 
as described by Bennett (204). Peptides were 
separated on polyamide plates. Solvent 1st 
dimension 1.5% formic acid, solvent 2nd dimension 
n-Heptrane/n-Butanol/acetic acid (3:3:1 v/v).
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preparations and proteolipid preparations from the 
parental strain during purification. Subunit 9 from a 
number of mutants had the same values as shown in Table 
6.2. Partial acid hydrolysis of the proteolipids from 
mutants and the parental strain gave different finger­
prints when separated on polyamide thin layers as shown 
in Figs. 6.7-, 6.8. and 6.9. D22 and the oligomycin
resistant mutant D22 A21 have almost identical peptide 
patterns, indicating no change in the primary strucute 
of subunit 9 in this mutant. The DCCD resistant mutant 
D22 61 has a different peptide map in that although there 
are five peptides identical to those from the parental 
strain, there is also a sixth new peptide. The peptide 
map produced by partial acid hydrolysis of D22 A19 is 
markedly altered in that in addition to the peptides found 
for the parental strain, two new peptides are produced, 
and the positions of the peptides are altered. Unfortun­
ately, some core protein is not digested by partial acid 
hydrolysis under the very mild conditions used, but 
hydrolyses in higher concentrations of acid were unsatis­
factory due to poor reproducibility.
6.4. Discussion
A major problem in the interpretation of binding data 
relating to multisubunit enzymes such as the oligomycin 
sensitive ATPase complex is that a lesion in one of the 
subunits may alter the conformation of the complex such 
that binding of ligand to a second subunit is diminished. 
For this reason, it has previously been difficult to relate
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TABLE 6.2. Relative mobilities of subunit 9 from
varying sources
r „ Sourcef
0.72 S. cerevisiae D22
0.72 S. cerevisiae D22 A15
0.70 S. cerevisiae D22 A19
0.72 S. cerevisiae DP? A21
0.73 S. cerevisiae D22 61
0.72 Beef Heart mitochondria
Crude proteoliuids extracted from submitochondrial 
particles with chloroform/methanol (2:1 v/v) and precip­
itated with diethyl ether as described by Cattell (78) 
were chromatographed on Silica Gel plates in chloroform/ 
methanol/17% NH^ (2:1:1 v/v/v). Spots were visualised 
with iodine vapour.
liyO.7
Partial acid hydrolysis of subunitO D22 A21
Hcptane/Dutanol/Acetic acid 
(3=3=1)
FIGURE 6.7.
Cleavage of ourified subunit 9 at 
asoartic acid vas performed as described by 
Tsung (207). Dansylated peptides were separated 
on polyamide plates. Solvent 1st dimension 
1.5% acetic acid, solvent'Pnd dimension Heptane/ 
Butanol/acetic acid (5:5=1 v/v). Dashed lines 
are peptides from D22 parental. Solid lines 
refer to peptides from the mutant strains.
1 7 «:
Fig 6.0
Partial acid hydrolysis of stsbunit 9 D22 61
FIGURE 6.8.
Cleavage of purified subunit 9 
at aspartic acid was performed as described 
by Tsung (207). Dansylated peptides were 
separated on polyamide plates. Solvent 1st 
dimension 1.6% acetic acid, solvent 2nd 
dimension Heotane/Butanol/acetic acid (3=3:'1 
v/v).
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FIGURE 6.9.
Cleavage of purified subunit 9 
at aspartic acid v;as performed as described 
by Tsung (207). Dansylated peptides were 
separated on polyamide plates. Solvent 1st 
dimension 1.5% acetic acid, solvent 2nd dimension 
Heptane/Butanol/acetic acid (5:5=1 v/v).
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the genetic evidence obtained with inhibitor resistant 
mutants, to specific binding sites in the OS-ATPase 
complex. The firidT'Tp; that DCCD binds to a specific 
subunit of the ATPase as described in Chapter 5 prompted 
an investigation of this subunit prepared from a series of 
mutants resistant to oligomycin, some of which were also 
resistant to DCCD. It has been found that proteolipid 
from the DCCD resistant mutants D22 A19 and D22 61 differs 
in primary structure from that prepared from the parental 
strain as determined by partial acid hydrolysis. This 
is good supoortive evidence for the conclusions reached 
in the previous chanter. A lesion induced in subunit 9, 
which has been shown to bind DCCD, would almost certainly 
decrease the degree of binding and decrease the sensitivity 
of the Comdex to the inhibitor, as found for both D22 A19 
and D22 61.
The 0L111 mutants D22 A19 and D22 61 are also 
resistant to oligomycin, as is the 0L1 mutant D22 A21.
D22 A21 subunit 9 does not differ from that of the 
parental strain. Without access to labelled oligomycin, 
one cannot rule out the possibility of subunit 9 being 
the binding site of oligomycin: the 0L111 mutants are 
resistant to oligomycin and the resistance to any inhibitor 
may arise as a cooperative effect between subunits.
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resistant to oligomycin, as is the 0L1 mutant D22 A21.
D22 A21 subunit 9 does not differ from that of the 
parental strain. Without access to labelled oligomycin, 
one cannot rule out the possibility of subunit 9 being 
the binding site of oligomycin: the 0L111 mutants are 
resistant to oligomycin and the resistance to any inhibitor 
may arise as a cooperative effect between subunits.
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